<SEC-DOCUMENT>0001104659-21-076921.txt : 20210604
<SEC-HEADER>0001104659-21-076921.hdr.sgml : 20210604
<ACCEPTANCE-DATETIME>20210604145513
ACCESSION NUMBER:		0001104659-21-076921
CONFORMED SUBMISSION TYPE:	N-CSRS
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210604
DATE AS OF CHANGE:		20210604
EFFECTIVENESS DATE:		20210604

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEKLA LIFE SCIENCES INVESTORS
		CENTRAL INDEX KEY:			0000884121
		IRS NUMBER:				043147016
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		N-CSRS
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-06565
		FILM NUMBER:		21996103

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H&Q LIFE SCIENCES INVESTORS
		DATE OF NAME CHANGE:	19920929
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-CSRS
<SEQUENCE>1
<FILENAME>tm213429-1_ncsrs.htm
<DESCRIPTION>N-CSRS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMB APPROVAL</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 52%; border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMB Number:</FONT></TD>
    <TD STYLE="width: 12%; border-right: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3235-0570</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expires:</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    31, 2022</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNITED STATES</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated average burden hours per response. . . . . . . . . . . . . . .20.6</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES AND EXCHANGE COMMISSION</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington, D.C. 20549</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;N-CSR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFIED SHAREHOLDER REPORT OF REGISTERED<BR>
MANAGEMENT INVESTMENT COMPANIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment Company Act file number</FONT></TD>
    <TD COLSPAN="7" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">811-06565</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="font-size: 14pt; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt">Tekla
    Life Sciences Investors</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact name of registrant as specified in charter)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="8" STYLE="border-bottom: Black 1pt solid; vertical-align: super; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
    Federal Street, 19<SUP>th</SUP>&nbsp;Floor, Boston, MA</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02110</FONT></TD></TR>
<TR>
    <TD COLSPAN="8" STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip code)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name and address of agent for service)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s telephone number, including area code:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">617-772-8500</FONT></TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of fiscal year end:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&nbsp;30</FONT></TD>
    <TD COLSPAN="6">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of reporting period:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid">October 1, 2020 to March 31, 2021</TD>
    <TD COLSPAN="4">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 16%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 16%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 1. REPORTS TO STOCKHOLDERS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Document name: 21-3429-2.aa-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<p style="margin:12pt 0pt 12pt 0pt;"><img src="j2134292_aa001.jpg"></p>
<p style="margin:12pt 0pt 12pt 0pt;"><img src="j2134292_aa002.jpg"></p>
<p style="margin:12pt 0pt 12pt 0pt;"><img src="j2134292_aa003.jpg"></p>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:30pt;"><b><i>Semiannual Report</i></b></font></p>
<p style="margin:8pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:13pt;">March 31, 2021</font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=1,FOLIO='',FILE='21-3429-2.aa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS </b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Distribution policy:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> The Fund has implemented a managed distribution policy (the Policy) that provides for quarterly distributions at a rate set by the Board of Trustees. Under the current Policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Policy would result in a return of capital to shareholders, if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with "yield" or "income."</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The amounts and sources of distributions reported in the Fund's notices pursuant to Section 19(a) of the Investment Company Act of 1940 are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that tells you how to report distributions for federal income tax purposes.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">You should not draw any conclusions about the Fund's investment performance from the amount of distributions pursuant to the Policy or from the terms of the Policy. The Policy has been established by the Trustees and may be changed or terminated by them without shareholder approval. The Trustees regularly review the Policy and the frequency and rate of distributions considering the purpose and effect of the Policy, the financial market environment, and the Fund's income, capital gains and capital available to pay distributions. The suspension or termination of the Policy could have the effect of creating a trading discount or widening an existing trading discount. At this time there are no reasonably foreseeable circumstances that might cause the Trustees to terminate the Policy.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Consider these risks before investing:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> As with any investment company that invests in equity securities, the Fund is subject to market risk&#151;the possibility that the prices of equity securities will decline over short or extended periods of time. As a result, the value of an investment in the Fund's shares will fluctuate with the market generally and market sectors in particular. You could lose money over short or long periods of time. Political and economic news can influence marketwide trends and can cause disruptions in the U.S. or world financial markets. Other factors may be ignored by the market as a whole but may cause movements in the price of one company's stock or the stock of companies in one or more industries. All of these factors may have a greater impact on initial public offerings and emerging company shares. Different types of equity securities tend to shift into and out of favor with investors, depending on market and economic conditions. The performance of funds that invest in equity securities of healthcare companies may at times be better or worse than the performance of funds that focus on other types of securities or that have a broader investment style.</font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=2,FOLIO='',FILE='21-3429-2.aa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>

<!-- Document name: 21-3429-2.ba-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dear Shareholders,</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">I think it is obvious in the United States and around the world that, over the last year, the COVID-19 epidemic has been the dominating factor in nearly everyone's lives, family and job, as well as in all aspects of the economy and markets. We have not been surprised by the volatility of these things but admit to not expecting what felt like an inexorable upward move in the market during the worst months of the pandemic. We report herein on the period September 30, 2020 to March 31, 2021. Fund performance for that period is described elsewhere in this report. But given the dynamics of the last year, we feel that we should speak to the bigger, Covid-related picture in our commentary.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">As you may well be aware, in the first part of 2020 nearly all equity markets we see as related to the Fund declined&#151;some as much as 30%&#151;in response to the infections, quarantines and deaths reported. However, those same markets rebounded impressively through the rest of the calendar year producing very positive results for calendar year 2020. For example, the S&amp;P 500<sup>&reg;</sup> Index* ("SPX") net advanced 18% in 2020. The broad S&amp;P Composite 1500<sup>&reg;</sup> Health Care Index* ("S15HLTH") trailed the SPX but still advanced approximately 14%. Interestingly, the NASDAQ Biotechtechnology Index<sup>&reg;</sup>* ("NBI") advanced approximately 26%. The SPDR<sup>&reg;</sup> S&amp;P<sup>&reg;</sup> Biotech ETF* ("XBI"), which tracks an index dominated by small-and mid-cap biotech companies, advanced approximately 48%, quite a dramatic result.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Much has been made of the markets' 2020 advance. Others have opined in great detail on this subject. In short, we think it is generally accepted that financial stimulus provided by the government and the promise of low interest rates promulgated by the Federal Reserve allowed and/or encouraged investment in the stock market (and in risk assets in particular) in preference to other asset classes.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;" align="center"><img src="j2134292_ba004.jpg">
</p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>1</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=3,FOLIO='1',FILE='21-3429-2.ba.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The first quarter of 2021 has been quite a different story. Things have been a bit more complicated. The broad SPX and S15HLTH advanced 6% and 3%, respectively with only moderate volatility in the first quarter of calendar year 2021. By contrast, the NBI and XBI have been much more volatile. The NBI was up almost 14% by early February but retraced this entire gain ending the quarter down fractionally. The small- and mid-cap focused XBI was up almost 24% by early February and retreated even more dramatically, declining by 22% in less than two months to end the quarter down by a few percent.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;" align="center"><img src="j2134292_ba005.jpg">
</p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The question of course is what happened to cause this situation and, more importantly, where are we going. From a personal point of view, we have all had a horrific year. More than thirty-two million Americans have contracted COVID-19 and well more than 500,000 individuals have died. Millions of children have had access to education reduced or eliminated. Millions of people have lost their jobs and we expect that hundreds of thousands of businesses have closed forever. Much of this loss cannot be recovered.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Having said this, we also need to evaluate where we are and where we expect to be as shareholders of the Fund. From a healthcare fund perspective, the view is a little more nuanced. From our perspective, COVID-19 arrived out of the blue. As described above, markets declined precipitously. Almost immediately, 200 companies started working on covid vaccines and therapeutics. Miraculously, biopharma partnered with the U.S. and other governments to approve multiple vaccines in a year (compared to a typical ten year development cycle).</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In parallel, we witnessed a vitriolic election cycle that changed a good deal of how government governs. We saw civil unrest that rivaled what we observed in the 1960's. A work from home world was created largely out of whole cloth. Simplistically, the economy unwound and then apparently rewound. </font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">A year later we find ourselves with still high unemployment, Covid case rates still dramatically higher than when we all went home, approaching 50% of the adult population vaccinated with herd immunity anticipated by some experts within the next few months, a push to get back to school </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>2</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=4,FOLIO='2',FILE='21-3429-2.ba.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">and to work, a separate and opposing push to continue working from home, a Federal Reserve committed to low interest rate for the foreseeable future, a government committed to continued stimulus and to increasing the safety net, the stock market higher than it was a year ago and what seems like generally positive sentiment. Whew!!</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">With respect to healthcare, what has all this produced? It was a banner, if volatile (particularly in the first quarter of 2021) year, for healthcare stock performance, a year of record investment in the sector, approximately 100 new biotech IPOs, an apparently less cooperative FDA, a hint (or more) of drug pricing pressure, first quarter company reporting results that look promising, healthcare trading at the biggest discount to the SPX in many years and, perhaps not surprisingly, quite a bit of uncertainty about where healthcare goes from here.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Having said all this, our view is pretty simple. We are fundamental analysts. We see attractive valuations, lots of innovation and a favorable macro environment (with low cost of capital and many companies well-funded). We think a fair analysis of all this is that it may well be a bumpy ride, but over any reasonable timeframe we see way more possibility for upside opportunity for the sector than for any extended downside pain.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Be well,</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="8" align="left" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<img src="j2134292_ba006.jpg">
<img src="j2134292_ba007.jpg">
</td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead<BR>President and Portfolio Manager</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>3</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=5,FOLIO='3',FILE='21-3429-2.ba.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Fund Essentials</b></font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Objective of the Fund</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies.</font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:3%">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Description of the Fund</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Life Sciences Investors ("HQL") is a non-diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQL. HQL primarily invests in the life sciences industries and will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Investment Philosophy</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Capital Management LLC, the Investment Adviser to the Fund, believes that:</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Aging demographics and adoption of new medical products and services can provide long-term tailwinds for healthcare companies</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Late stage biotechnology product pipeline could lead to significant increases in biotechnology sales</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Robust M&amp;A activity in healthcare may create additional investment opportunities</font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:0%">
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Fund Overview and Characteristics </b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">as of 3/31/21</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Market Price<sup>1</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="63" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>19.71</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">NAV<sup>2</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="63" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>20.70</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Premium/(Discount)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="63" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>-4.78</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>%</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Average 30 Day Volume</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="63" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>88,865</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Net Assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="63" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>502,677,966</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Ticker</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="104" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>HQL</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">NAV Ticker</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="104" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>XHQLX</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Commencement of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Operations Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="104" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>5/8/92</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Fiscal Year to Date <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Distributions<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Per Share</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="63" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>0.85</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i><sup>1</sup></i><i> The closing price at which the Fund's shares were traded on the exchange.</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i><sup>2</sup></i><i> Per-share dollar value of the Fund, calculated by dividing the total value of all the securities in its portfolio, plus any other assets and less liabilities, by the number of Fund shares outstanding.</i></font></p>
</div>
<div style="clear:both"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Holdings of the Fund</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Data is based on net assets)</i></font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:3%">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Asset Allocation as of 3/31/21</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><img src="j2134292_ba008.jpg">
</p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:0%">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Sector Diversification as of 3/31/21</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><img src="j2134292_ba009.jpg">
</p>
</div>
<div style="clear:both"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><i>This data is subject to change on a daily basis.</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>4</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=6,FOLIO='4',FILE='21-3429-2.ba.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Largest Holdings By Issuer</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>(Excludes Short-Term Investments)</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>As of March 31, 2021<BR>(Unaudited)</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:11pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Issuer &#150; </b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Sector</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:11pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>% of Net <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Assets</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Gilead Sciences, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">7.1</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Amgen, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5.7</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Illumina, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Life Sciences Tools &amp; Services</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5.5</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Vertex Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5.0</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Moderna, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.5</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Regeneron Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.2</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Biogen, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3.8</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Horizon Therapeutics plc</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3.7</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Seagen, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.6</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Guardant Health, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Health Care Equipment &amp; Supplies</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.9</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Alexion Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.8</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Alnylam Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.7</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Neurocrine Biosciences, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.4</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Syneos Health, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Healthcare Services</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.4</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Novavax, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.3</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Argenx SE</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.3</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CRISPR Therapeutics AG</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.2</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Allakos, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.2</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Exact Sciences Corp.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.1</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="247" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Fate Therapeutics, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.1</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:12pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Portfolio Highlights as of March 31, 2021</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Among other investments, Tekla Life Sciences Investors' performance benefitted in the past six months by the following:</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Fate Therapeutics, Inc. (FATE)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is developing an oncology treatment using so-called natural killer or NK cells which are part of the body's own innate defense system against cancer. The Fund was overweight the stock during the period where price appreciation coincided with positive clinical trial updates.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Sutro Biopharma, Inc. (STRO)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is an oncology-focused company with a novel antibody conjugate platform. In Q4 of 2020, the stock rose after </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>5</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=7,FOLIO='5',FILE='21-3429-2.ba.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">the Company announced promising data in ovarian cancer for its lead drug candidate. We were overweight the stock during this period.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Novavax, Inc. (NVAX)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is a vaccine developer with a novel recombinant platform. Based on strong immune stimulation activity against the COVID-19 virus with early clinical data, the Company's stock has performed strongly while we were overweight in the Fund.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Among other examples, Tekla Life Sciences Investors' performance was negatively impacted by the following investments:</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Moderna, Inc. (MRNA)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is a vaccine company based on a new therapeutic modality, messenger RNA. The Company has multiple development programs in the clinic but is most well-known for its commercially successful vaccine candidate targeting the COVID-19 virus. The Fund owned MRNA but was underweight during its recent runup.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Denali Therapeutics Inc. (DNLI)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is a biotechnology company that discovers and develops novel drugs for neurodegenerative diseases. Last year, the Company presented positive preliminary data which caused the stock to more than double while we were net underweight.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Bridgebio Pharma, Inc. (BBIO)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> operates as a biotechnology holding company within which subsidiaries have a pipeline of over 20 programs in genetic disease and cancer. Its stock rose due to continued investor enthusiasm for Eidos Therapeutics, a partially-owned subsidiary developing a treatment for cardio-myopathies related to heart failure. We were underweight BBIO during this period which saw the Company purchase all remaining outstanding shares of Eidos.</font></p>
<p style="margin:12pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Fund Performance</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">HQL is a closed-end fund which invests predominantly in life science companies. Subject to regular consideration, the Trustees of HQL have instituted a policy of making quarterly distributions to shareholders. The Fund seeks to make such distributions in the form of long-term capital gains.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund considers investments in companies of all sizes and in all life science subsectors, including but not limited to, biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare, healthcare technology, and healthcare facilities. The Fund emphasizes innovation, investing both in public and pre-public venture companies. The Fund considers its venture investments to be a differentiating characteristic. Among the various healthcare subsectors, HQL has considered the </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>6</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=8,FOLIO='6',FILE='21-3429-2.ba.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">biotechnology subsector, including both pre-public and public companies, to be a key contributor to the healthcare sector. The Fund holds biotech assets, including both public and pre-public, often representing 65-80% of net assets.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">There is no commonly published index which matches the investment strategy of HQL. The S15HLTH consists of approximately 170 companies representing most or all of the healthcare subsectors in which HQL typically invests; biotechnology often represents 15-20% of this index. By contrast, the NBI, which contains over 270 constituents, is much more narrowly constructed. The vast majority of this index is comprised of biotechnology, pharmaceutical and life science tools companies. In recent years, biotechnology has often represented 72-82% of the NBI. Neither the S15HLTH nor NBI indices contain any material amount of pre-public company assets.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Given the circumstances, we present both NAV and stock returns for the Fund in comparison to several commonly published indices. One index, the SPX, is a commonly considered broad based index; this index is comprised of companies in many areas of the economy, including, but not limited to healthcare. As described above, the NBI is a healthcare index mostly focused in three healthcare sectors with a uniquely high level of biotechnology comparison. The S15HLTH contains a wider representation of healthcare subsectors, but typically contains a much lower biotechnology composition.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">HQL generally invests in a combination of large-cap growth-oriented and earlier stage innovative healthcare companies with a focus on the biotechnology sector. Generally, HQL targets biotechnology exposure below that of the NBI and a higher biotechnology exposure than that of the S15HLTH. We note that in recent periods, biotechnology has been a significant contributor to returns (both positive and negative) associated with those indices. We believe this sector continues to have significant potential for growth in the future.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>6 Month Index Performance Ending March 31, 2021</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j2134292_ba010.jpg">
</p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>7</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=9,FOLIO='7',FILE='21-3429-2.ba.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Fund Performance for the Period Ended March 31, 2021</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="48" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Period</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>HQL NAV</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="70" align="center" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>HQL MKT</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="52" align="center" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>NBI</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>S15HLTH</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="52" align="center" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>SPX</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="48" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">month</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6.60</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="54" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">16.92</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">11.34</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">12.58</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">19.06</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="48" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">year</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">31.70</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="54" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">43.06</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">40.12</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">35.94</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">56.33</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="48" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">year</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">12.05</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="54" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">11.49</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">12.21</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">14.12</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">16.28</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="48" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">10 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">year</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">14.83</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="54" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">15.13</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">16.84</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">15.82</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">13.90</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:9pt 0pt 0pt 0pt;" align="center"><img src="j2134292_ba011.jpg">
</p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>All performance over one-year has been annualized.</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Performance data quoted represents past performance, which is no guarantee of future results, and current performance may be lower or higher than the figures shown. The NAV total return takes into account the Fund's total annual expenses and does not reflect transaction charges. If transaction charges were reflected, NAV total return would be reduced. All distributions are assumed to be reinvested either in accordance with the dividend reinvestment plan (DRIP) for market price returns or NAV for NAV returns. Until the DRIP price is available from the Plan Agent, the market price returns reflect the reinvestment at the closing market price on the last business day of the month. Once the DRIP is available around mid-month, the market price returns are updated to reflect reinvestment at the DRIP price.</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">*The trademarks NASDAQ Biotechnology Index<sup>&reg;</sup>, S&amp;P Composite 1500<sup>&reg;</sup> Health Care Index, SPDR<sup>&reg;</sup> S&amp;P<sup>&reg;</sup> Biotech ETF and S&amp;P 500<sup>&reg;</sup> Index referenced in this report are the property of their respective owners. These trademarks are not owned by or associated with the Fund or its service providers, including Tekla Capital Management LLC.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>8</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=10,FOLIO='8',FILE='21-3429-2.ba.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>

<!-- Document name: 21-3429-2.ca-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Unaudited)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="94" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CONVERTIBLE PREFERRED<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>(Restricted) </b><b><sup>(a) (b)</sup></b><b> - 4.7% of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology - 3.8%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="101" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">140,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Amphivena Therapeutics, Inc. Series B, 6.00%</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,100,000</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">225,416</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Amphivena Therapeutics, Inc. Series C, 6.00%</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">808,848</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">848,333</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Arkuda Therapeutics, Inc. Series A, 6.00%</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,018,184</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">79,099</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Caribou Biosciences, Inc. Series C, 8.00%</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,365,012</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">103,675</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Dynacure Series C <sup>(c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,579,921</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">645,834</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Hotspot Therapeutics, Inc. Series B, 6.00%</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,550,002</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,229,167</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Invetx, Inc. Series A</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,550,000</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">117,704</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Oculis SA, Series B2, 6.00% <sup>(c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,036,876</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">41,067</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Priothera Ltd. Series A, 6.00%</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">481,593</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,166,606</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Pyxis Oncology, Inc. Series B</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,920,000</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,153,847</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Rainier Therapeutics, Inc. Series A, 6.00%</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">115</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">668,449</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Rainier Therapeutics, Inc. Series B, 6.00%</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">124,332</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,229,766</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Rallybio Holdings, LLC Series B</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,100,044</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">345,010</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Vectivbio Holding AG Series A2, 6.00%</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">397,106</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="337" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">19,032,033</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="344" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Health Care Equipment &amp; Supplies - 0.3%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">362,887</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">IO Light Holdings, Inc. Series A2</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,397,369</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals - 0.6%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="101" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,719,854</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Curasen Therapeutics, Inc. Series A</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,999,999</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>TOTAL CONVERTIBLE PREFERRED<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(Cost $24,407,843)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">23,429,401</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>COMMON STOCKS AND WARRANTS - 93.7% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology - 71.9%</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">111,776</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">ACADIA Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,883,821</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">104,312</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Affimed N.V. <sup>(a) (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">825,108</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">59,698</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Alexion Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">9,128,421</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">60,092</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Alkermes plc <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,122,519</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">53,427</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Allakos, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6,132,351</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">62,136</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Alnylam Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">8,772,982</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">115,240</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Amgen, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">28,672,864</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">217,266</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Amicus Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,146,588</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">82,121</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Apellis Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,523,812</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">32,461</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">ARCA biopharma, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">118,483</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">18,027</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">ARCA biopharma, Inc. Warrants (expiration <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">06/11/22, exercise price $1.10) <sup>(a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">180</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>9</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=11,FOLIO='9',FILE='21-3429-2.ca.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Unaudited, continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="94" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - continued</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">44,764</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Arcutis Biotherapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,295,023</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">289,336</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Ardelyx, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,915,404</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">67,473</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Arena Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,681,951</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">23,128</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Argenx SE <sup>(a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6,369,220</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">52,166</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Arrowhead Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,459,127</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">41,459</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Ascendis Pharma A/S <sup>(a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5,343,236</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">48,919</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Atreca, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">749,928</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">12,109</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">BeiGene Ltd. <sup>(a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,214,901</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Bellicum Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">22,560</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">67,462</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Biogen, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">18,872,495</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">56,850</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">BioMarin Pharmaceutical, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,292,744</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">21,672</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">BioNTech SE <sup>(a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,366,366</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">41,586</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Black Diamond Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,008,876</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">45,530</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Blueprint Medicines Corp. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,426,882</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">23,337</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Bridgebio Pharma, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,437,559</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">53,779</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">ChemoCentryx, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,755,636</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">168,782</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Cogent Biosciences, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,481,906</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">154,310</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Corbus Pharmaceuticals Holdings, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">303,991</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">51,536</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">CRISPR Therapeutics AG <sup>(a) (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6,279,662</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">32,636</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">CymaBay Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">148,167</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">84,072</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Deciphera Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,769,788</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">56,397</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Denali Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,220,269</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">21,531</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Dicerna Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">550,548</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">15,190</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Editas Medicine, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">637,980</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">42,839</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Exact Sciences Corp. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5,645,323</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">229,590</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Exelixis, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5,186,438</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">66,790</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Fate Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5,506,836</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">53,186</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Forma Therapeutics Holdings, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,490,272</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">122,990</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">G1 Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,959,139</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">145,858</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Galera Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,286,468</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">118,142</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Gamida Cell Ltd. <sup>(a) (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">955,769</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">29,963</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Genmab A/S <sup>(a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">983,685</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">551,520</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Gilead Sciences, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">35,644,738</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">26,109</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">I-Mab <sup>(a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,265,503</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">25,486</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Incyte Corp. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,071,247</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">37,238</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Insmed, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,268,326</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">19,823</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Intellia Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,590,895</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">18,630</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Intercept Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">429,980</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">98,313</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Ionis Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,420,152</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">138,993</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Iovance Biotherapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,400,518</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">120,324</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Jounce Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,235,727</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">15,797</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">KalVista Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">405,825</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">28,463</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Karuna Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,422,107</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>10</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=12,FOLIO='10',FILE='21-3429-2.ca.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Unaudited, continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="94" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - continued</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">95,149</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Kura Oncology, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,689,862</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">314,585</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Mereo Biopharma Group plc <sup>(a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,060,151</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">172,282</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Moderna, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">22,560,328</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">95,811</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Molecular Templates, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,209,135</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">28,213</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Morphic Holding, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,785,319</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">37,223</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Nektar Therapeutics <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">744,460</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">71,328</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Neurocrine Biosciences, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6,936,648</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">44,550</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">NexGel, Inc. <sup>(a) (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">138</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">28,988</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Nkarta, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">953,705</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">36,998</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Novavax, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6,708,107</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">111,820</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Ovid Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">449,516</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">264,669</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Pieris Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">680,199</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">23,821</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Pieris Pharmaceuticals, Inc., Series A Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(expiration 06/08/21, exercise price $3.00) <sup>(a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,859</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">11,911</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Pieris Pharmaceuticals, Inc., Series B Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(expiration 06/08/21, exercise price $2.00) <sup>(a) (b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5,717</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">23,594</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Praxis Precision Medicines, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">772,939</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">19,832</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Precision BioSciences, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">205,261</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">44,812</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Regeneron Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">21,202,350</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">76,500</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Replimune Group, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,334,015</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">39,422</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Sage Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,950,737</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">35,334</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Sarepta Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,633,443</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">17,193</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Scholar Rock Holding Corp. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">870,997</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">95,761</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Seagen, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">13,297,372</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">172,491</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Sutro Biopharma, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,925,895</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">76,396</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">TCR2 Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,686,824</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">70,155</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Travere Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,751,770</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">157,719</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Trillium Therapeutics, Inc. <sup>(a) (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,693,902</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">29,770</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Ultragenyx Pharmaceutical, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,389,612</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">42,765</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">uniQure N.V. <sup>(a) (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,440,753</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">20,511</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">United Therapeutics Corp. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,430,875</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">375,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Vectivbio Holding AG (Restricted) <sup>(a) (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">296,250</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">117,437</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Vertex Pharmaceuticals, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">25,236,037</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">25,600</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Vir Biotechnology, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,312,512</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">54,032</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Xenon Pharmaceuticals, Inc. <sup>(a) (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">967,173</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">62,055</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Y-mAbs Therapeutics, Inc. <sup>(a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,876,543</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">11,502</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Zai Lab Ltd. <sup>(a) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,534,712</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="337" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">361,696,412</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Health Care Equipment &amp; Supplies </i><i><sup>(a)</sup></i><i> - 3.0%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="101" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">130,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Cercacor Laboratories, Inc. (Restricted) <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,429,690</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">61,400</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Guardant Health, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">9,372,710</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">8,329</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">IDEXX Laboratories, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,075,463</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="337" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">14,877,863</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>11</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=13,FOLIO='11',FILE='21-3429-2.ca.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Unaudited, continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="94" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Providers &amp; Services </i><i><sup>(a) </sup></i><i>- 0.2%</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">148,148</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">InnovaCare, Inc. Escrow Shares (Restricted) <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">70,415</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5,822</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Medpace Holdings, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">955,099</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="337" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,025,514</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="344" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Healthcare Services </i><i><sup>(a)</sup></i><i> - 1.4%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">91,070</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Syneos Health, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6,907,660</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="344" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Life Sciences Tools &amp; Services </i><i><sup>(a)</sup></i><i> - 7.6%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">121,513</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Adaptive Biotechnologies Corp.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,892,113</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">71,882</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Illumina, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">27,607,001</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">58,816</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Personalis, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,447,462</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">27,493</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">PRA Health Sciences, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,215,502</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="337" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">38,162,078</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="344" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals </i><i><sup>(a)</sup></i><i> - 9.5%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">34,619</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Arvinas, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,288,316</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">127,109</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Aurinia Pharmaceuticals, Inc. <sup>(c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,650,510</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">165,330</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Clearside Biomedical, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">408,365</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">29,100</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Endo International plc <sup>(c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">215,631</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">40,585</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Heron Therapeutics, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">657,883</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">202,404</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Horizon Therapeutics plc <sup>(c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">18,629,264</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">77,580</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Intra-Cellular Therapies, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,632,289</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">25,203</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Jazz Pharmaceuticals plc <sup>(c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,142,617</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,060</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Madrigal Pharmaceuticals, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">474,898</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">28,691</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Mirati Therapeutics, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,914,768</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">12,440</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Reata Pharmaceuticals, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,240,268</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">34,880</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Spectrum Pharmaceuticals, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">113,709</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">14,218</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Tetraphase Pharmaceuticals, Inc. CVR <sup>(e)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,844</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">141,641</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Theravance Biopharma, Inc. <sup>(c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,890,893</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">41,021</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Turning Point Therapeutics, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3,880,176</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">315,800</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Verona Pharma plc <sup>(d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,640,088</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">371,622</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Verona Pharma plc Warrants (expiration <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">04/27/22, exercise price $2.85) <sup>(b) (c)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">7,685</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">40,620</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">VYNE Therapeutics, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">278,044</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">37,281</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Zogenix, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">727,725</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="337" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">47,795,973</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="344" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Special Purpose Acquisition Company </i><i><sup>(a)</sup></i><i> - 0.1%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">78,403</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Helix Acquisition Corp.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">802,455</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>TOTAL COMMON STOCKS AND WARRANTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(Cost $344,760,653)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">471,267,955</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>12</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=14,FOLIO='12',FILE='21-3429-2.ca.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Unaudited, continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="94" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>PRINCIPAL<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>AMOUNT</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHORT-TERM INVESTMENT - 0.2% of Net Assets<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,047,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Repurchase Agreement, Fixed Income Clearing <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Corp., repurchase value $1,047,000, 0.00%, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">dated 03/31/21, due 04/01/21 (collateralized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">by U.S. Treasury Note 0.50%, due 04/15/24, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">market value $1,068,023)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,047,000</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>TOTAL SHORT-TERM INVESTMENT<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(Cost $1,047,000)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,047,000</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>TOTAL INVESTMENTS BEFORE MILESTONE <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>INTERESTS - 98.6%<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(Cost $370,215,496)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">495,744,356</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>INTERESTS</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>MILESTONE INTERESTS (Restricted) </b><b><sup>(a) (b)</sup></b><b> - 1.5% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology - 0.1%</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Therachon Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">585,481</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Health Care Equipment &amp; Supplies - 0.0%</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Therox Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1,727</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals - 1.4%</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Afferent Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">291,920</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Ethismos Research Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">0</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Impact Biomedicines Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2,290,972</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Neurovance Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4,283,437</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="337" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6,866,329</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>TOTAL MILESTONE INTERESTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(Cost $4,602,125)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">7,453,537</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>TOTAL INVESTMENTS - 100.1%<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(Cost $374,817,621)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">503,197,893</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>OTHER LIABILITIES IN EXCESS OF <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>AS</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SETS - (0.1)%</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(519,927</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>NET ASSETS - 100%</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">502,677,966</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:12pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(a)&nbsp;&nbsp;Non-income producing security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(b)&nbsp;&nbsp;Security fair valued using significant unobservable inputs. See Investment Valuation and Fair Value Measurements.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(c)&nbsp;&nbsp;Foreign security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(d)&nbsp;&nbsp;American Depository Receipt</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(e)&nbsp;&nbsp;Contingent Value Right</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>13</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=15,FOLIO='13',FILE='21-3429-2.ca.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>

<!-- Document name: 21-3429-2.da-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:18pt;"><b> </b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENT OF ASSETS AND LIABILITIES</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Unaudited)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ASSETS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments, at value (cost $370,215,496)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">495,744,356</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone interests, at value (cost $4,602,125)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,453,537</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total investments</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">503,197,893</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cash</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">159</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Receivable for investments sold</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,409</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Prepaid expenses</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">43,807</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Other assets (see Note 1)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">80,325</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">503,327,593</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">LIABILITIES:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Payable for investments purchased</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">44,080</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued advisory fee</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">460,597</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued investor support service fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">21,990</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued shareholder reporting fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">45,888</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued other</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">77,072</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:2pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total liabilities</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">649,627</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Commitments and Contingencies (see Notes 1 and 4)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="106" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET ASSETS</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">502,677,966</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">SOURCES OF NET ASSETS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shares of beneficial interest, par value $.01 per share, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">unlimited number of shares authorized, amount <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">paid in on 24,279,438 shares issued and outstanding</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">242,794</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Additional paid-in-capital</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">364,247,380</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total distributable earnings (loss)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">138,187,792</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total net assets (equivalent to $20.70 per share <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">based on 24,279,438 shares outstanding)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">502,677,966</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>14</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=16,FOLIO='14',FILE='21-3429-2.da.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:18pt;"><b> </b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENT OF OPERATIONS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SIX MONTHS ENDED MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Unaudited)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">INVESTMENT INCOME:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dividend income</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,108,619</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total investment income</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,108,619</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">EXPENSES:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Advisory fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,577,942</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investor support service fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">127,802</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Trustees' fees and expenses</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">71,120</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Custodian fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">60,445</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Administration fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">58,848</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Auditing fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">54,888</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholder reporting</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">47,876</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Legal fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">32,441</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Transfer agent fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,110</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Other (see Note 2)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">70,981</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total expenses</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,129,453</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:10pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net investment loss</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(2,020,834</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">REALIZED AND UNREALIZED GAIN (LOSS):</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain (loss) on:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,855,872</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Closed or expired option contracts written</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">68,126</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Foreign currency transactions</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(7,830</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,916,168</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net change in unrealized appreciation (depreciation) on:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,092,933</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone interests</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(1,384,947</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Option contracts written</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(56,040</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net change in unrealized appreciation (depreciation)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,651,946</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized and unrealized gain (loss)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">33,568,114</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase in net assets resulting from <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">31,547,280</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>15</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=17,FOLIO='15',FILE='21-3429-2.da.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:18pt;"><b> </b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENTS OF CHANGES IN NET ASSETS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="184" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="136" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Six months ended<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">March 31, 2021 <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Unaudited)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="122" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Year ended<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">September 30, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2020</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="450" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET INCREASE (DECREASE) IN NET <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ASSETS RESULTING FROM OPERATIONS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net investment loss</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="93" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,020,834</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,114,692</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,916,168</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">35,668,840</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Change in net unrealized appreciation</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,651,946</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">89,498,852</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase in net assets resulting <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">31,547,280</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">123,053,000</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">DISTRIBUTIONS TO SHAREHOLDERS <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(See Note 1):</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(20,389,355</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(34,380,780</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="450" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CAPITAL SHARE TRANSACTIONS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Reinvestment of distributions <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(396,286 and 839,942 shares, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">respectively)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,949,665</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,438,152</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Fund shares repurchased (0 and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">136,700 shares, respectively) <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(see Note 1)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(2,191,362</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total capital share transactions</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,949,665</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,246,790</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase in net assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">19,107,590</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">99,919,010</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="450" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET ASSETS:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Beginning of period</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">483,570,376</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">383,651,366</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">End of period</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="93" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">502,677,966</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">483,570,376</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>16</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=18,FOLIO='16',FILE='21-3429-2.da.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>

<!-- Document name: 21-3429-2.ea-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>FINANCIAL HIGHLIGHTS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="110" valign="bottom" style="padding:0pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:0pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Six months <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">ended <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">March 31, 2021</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="19" width="406" align="center" valign="bottom" style="padding:0pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">For the years ended September 30,</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(Unaudited)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2020</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2019</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2018</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2016</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="632" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>OPERATING PERFORMANCE FOR A SHARE <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>OUTSTANDING THROUGHOUT EACH PERIOD</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net asset value per share, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">beginning of period</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.25</font></p></td>
<td colspan="1" width="28" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">16.55</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.22</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.62</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">23.51</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net investment loss <sup>(1)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.08</font></p></td>
<td colspan="1" width="28" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.09</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.13</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.16</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.18</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.19</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized and unrealized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">gain (loss)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.38</font></p></td>
<td colspan="1" width="28" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5.25</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3.06</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.39</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.39</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.47</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total increase (decrease) <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from investment operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.30</font></p></td>
<td colspan="1" width="28" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5.16</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3.19</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.23</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.21</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.66</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="632" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Distributions to shareholders from:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net investment income</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="28" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.13</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.38</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)<sup>(2)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.05</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)<sup>(2)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized capital gains</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.85</font></p></td>
<td colspan="1" width="28" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.47</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.36</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.25</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)<sup>(2)</sup></font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.54</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)<sup>(2)</sup></font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.85</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total distributions</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.85</font></p></td>
<td colspan="1" width="28" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.47</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.49</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.63</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.59</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.85</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Increase resulting from <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">shares repurchased <sup>(1)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="28" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.01</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.01</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><sup>(3)</sup></font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net asset value per share, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">end of period</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.70</font></p></td>
<td colspan="1" width="28" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.25</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">16.55</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.22</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.62</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Per share market value, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">end of period</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">19.71</font></p></td>
<td colspan="1" width="28" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">17.58</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15.10</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.42</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.48</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">18.73</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total investment return <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">at market value</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">16.92</font></p></td>
<td colspan="1" width="28" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%*</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">27.50</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(18.86</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.31</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">24.26</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(4.66</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total investment return <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">at net asset value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6.60</font></p></td>
<td colspan="1" width="28" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%*</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">34.00</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(14.38</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6.61</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">17.12</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.52</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="632" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>RATIOS</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net investment loss to average <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">net assets</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.79</font></p></td>
<td colspan="1" width="28" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)**</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.47</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.70</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.81</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.92</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.92</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Expenses to average net assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.22</font></p></td>
<td colspan="1" width="28" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%**</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.22</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.29</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.25</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.32</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.27</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="632" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>SUPPLEMENTAL DATA</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net assets at end of period <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(in millions)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">503</font></p></td>
<td colspan="1" width="28" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">484</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">384</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">475</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">466</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">415</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Portfolio turnover rate</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">39.87</font></p></td>
<td colspan="1" width="28" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%*</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">51.27</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">43.78</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">37.49</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">43.08</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">30.99</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;">*&nbsp;&nbsp;Not annualized.</font></p>
<p style="margin:1.5pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;">**&nbsp;&nbsp;Annualized.</font></p>
<p style="margin:1.5pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;">(1)&nbsp;&nbsp;Computed using average shares outstanding.</font></p>
<p style="margin:1.5pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;">(2)&nbsp;&nbsp;Amount previously presented incorrectly as solely distributions from net realized capital gains has been revised to reflect the proper classification.</font></p>
<p style="margin:1.5pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;">(3)&nbsp;&nbsp;Amount represents less than $0.005 per share.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>17</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=19,FOLIO='17',FILE='21-3429-2.ea.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>

<!-- Document name: 21-3429-2.fa-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Unaudited)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>(1)&nbsp;&nbsp;Organization and Significant Accounting Policies</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tekla Life Sciences Investors (the Fund) is a Massachusetts business trust formed on February 20, 1992, and registered under the Investment Company Act of 1940 as a non-diversified closed-end management investment company. The Fund commenced operations on May 8, 1992. The Fund's investment objective is long-term capital appreciation through investment in U.S. and foreign companies in the life sciences industry (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management. The Fund invests primarily in securities of public and private companies that are believed by the Fund's Investment Adviser, Tekla Capital Management LLC (the Adviser), to have significant potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of U.S. issuers that are traded primarily in foreign markets.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The preparation of these financial statements requires the use of certain estimates by management in determining the Fund's assets, liabilities, revenues and expenses. Actual results could differ from these estimates and such differences could be material. The following is a summary of significant accounting policies followed by the Fund, which are in conformity with accounting principles generally accepted in the United States of America (GAAP). The Fund is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board Accounting Standards Codification 946. Events or transactions occurring after March 31, 2021, through the date that the financial statements were issued, have been evaluated in the preparation of these financial statements.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The impact of the COVID-19 outbreak on the financial performance of the Fund's investments will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of COVID-19 on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Fund's future investment results may be materially adversely affected.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Investment Valuation</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shares of publicly traded companies listed on national securities exchanges or trading in the over-the-counter market are typically valued at the last sale price, </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>18</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=20,FOLIO='18',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">as of the close of trading, generally 4 p.m., Eastern Time. The Board of Trustees of the Fund (the Trustees) has established and approved fair valuation policies and procedures with respect to securities for which quoted prices may not be available or which do not reflect fair value. Convertible, corporate and government bonds are valued using a third-party pricing service. Convertible bonds are valued using this pricing service only on days when there is no sale reported. Restricted securities of companies that are publicly traded are typically valued based on the closing market quote on the valuation date adjusted for the impact of the restriction as determined in good faith by the Adviser also using fair valuation policies and procedures approved by the Trustees described below. Non-exchange traded warrants of publicly traded companies are generally valued using the Black-Scholes model, which incorporates both observable and unobservable inputs. Short-term investments with a maturity of 60 days or less are generally valued at amortized cost, which approximates fair value.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Convertible preferred shares, warrants or convertible note interests in private companies, milestone interests and other restricted securities, as well as shares of publicly traded companies for which market quotations are not readily available, such as stocks for which trading has been halted or for which there are no current day sales, or which do not reflect fair value, are typically valued in good faith, based upon the recommendations made by the Adviser pursuant to fair valuation policies and procedures approved by the Trustees.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Adviser has a Valuation Sub-Committee comprised of senior management which reports to the Valuation Committee of the Board at least quarterly. Each fair value determination is based on a consideration of relevant factors, including both observable and unobservable inputs. Observable and unobservable inputs the Adviser considers may include (i) the existence of any contractual restrictions on the disposition of securities; (ii) information obtained from the company, which may include an analysis of the company's financial statements, products, intended markets or technologies; (iii) the price of the same or similar security negotiated at arm's length in an issuer's completed subsequent round of financing; (iv) the price and extent of public trading in similar securities of the issuer or of comparable companies; or (v) a probability and time value adjusted analysis of contractual terms. Where available and appropriate, multiple valuation methodologies are applied to confirm fair value. Significant unobservable inputs identified by the Adviser are often used in the fair value determination. A significant change in any of these inputs may result in a significant change in the fair value measurement. Due to the uncertainty inherent in the </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>19</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=21,FOLIO='19',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">valuation process, such estimates of fair value may differ significantly from the values that would have been used had a ready market for the investments existed, and differences could be material. Additionally, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different from the valuations used at the date of these financial statements.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Milestone Interests</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund holds financial instruments which reflect the current value of future milestone payments the Fund may receive as a result of contractual obligations from other parties. The value of such payments are adjusted to reflect the estimated risk based on the relative uncertainty of both the timing and the achievement of individual milestones. A risk to the Fund is that the milestones will not be achieved and no payment will be received by the Fund. The milestone interests were received as part of the proceeds from the sale of six private companies. Any payments received are treated as a reduction of the cost basis of the milestone interest with payments received in excess of the cost basis treated as a realized gain. The contractual obligations with respect to the milestone interests provide for payments at various stages of the development of Afferent, Ethismos Research, Neurovance, Impact Biomedicines, Therachon and Therox's principal product candidate as of the date of the sale.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The following is a summary of the impact of the milestone interests on the financial statements as of and for the six months ended March 31, 2021:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="273" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Assets and Liabilities, Milestone interests, at value</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">7,453,537</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="273" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Assets and Liabilities, total distributable earnings</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">2,851,412</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="273" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Operations, Change in unrealized appreciation (depreciation)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">on Milestone interests</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">($</font></p></td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">1,384,947</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Options on Securities</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">An option contract is a contract in which the writer (seller) of the option grants the buyer of the option, upon payment of a premium, the right to purchase from (call option) or sell to (put option) the writer a designated instrument at a specified price within a specified period of time. Certain options, including options on indices, will require cash settlement by the Fund if the option is exercised. The Fund enters into option contracts in order to hedge against potential adverse price movements in the value of portfolio assets, as a temporary substitute for selling selected investments, to lock in the purchase price of a </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>20</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=22,FOLIO='20',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">security or currency which it expects to purchase in the near future, as a temporary substitute for purchasing selected investments, or to enhance potential gain or to gain or hedge exposure to financial market risk.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's obligation under an exchange traded written option or investment in an exchange traded purchased option is valued at the last sale price or in the absence of a sale, the mean between the closing bid and asked prices. Gain or loss is recognized when the option contract expires, is exercised or is closed.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">If the Fund writes a covered call option, the Fund foregoes, in exchange for the premium, the opportunity to profit during the option period from an increase in the market value of the underlying security above the exercise price. If the Fund writes a put option it accepts the risk of a decline in the market value of the underlying security below the exercise price. Over-the-counter options have the risk of the potential inability of counterparties to meet the terms of their contracts. The Fund's maximum exposure to purchased options is limited to the premium initially paid. In addition, certain risks may arise upon entering into option contracts including the risk that an illiquid secondary market will limit the Fund's ability to close out an option contract prior to the expiration date and that a change in the value of the option contract may not correlate exactly with changes in the value of the securities or currencies hedged.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">All options on securities and securities indices written by the Fund are required to be covered. When the Fund writes a call option, this means that during the life of the option the Fund may own or have the contractual right to acquire the securities subject to the option or may maintain with the Fund's custodian in a segregated account appropriate liquid securities in an amount at least equal to the market value of the securities underlying the option. When the Fund writes a put option, this means that the Fund will maintain with the Fund's custodian in a segregated account appropriate liquid securities in an amount at least equal to the exercise price of the option.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The average number of outstanding options purchased for the six months ended March 31, 2021 was 73.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>21</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=23,FOLIO='21',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="111" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Derivatives not accounted <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">for as hedging instruments <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">under ASC 815</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="129" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Assets and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Liabilities Location</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="186" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Operations Location</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equity Contracts<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="14" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="85" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Assets: Investments, at <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="28" bgcolor="#cceeff" align="right" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="100" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized gain (loss) on <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="46" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">173,308</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="71" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="14" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="18" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="85" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="44" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="100" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Change in unrealized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">appreciation (depreciation) <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">on investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="46" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$16,708</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="14" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="85" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Liabilities: Options <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">written, at value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="28" bgcolor="#cceeff" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$&#151;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="100" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized gain (loss) on<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">closed or expired option<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">contracts written</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="46" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$68,126</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="71" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="14" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="18" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="85" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="44" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="100" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Change in unrealized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">appreciation (depreciation) <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">on option contracts written</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="46" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($56,040)</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Other Assets</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Other assets in the Statement of Assets and Liabilities consists of amounts due to the Fund at various times in the future in connection with the sale of investments in three private companies.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Investment Transactions and Income</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investment transactions are recorded on a trade date basis. Gains and losses from sales of investments are recorded using the "identified cost" method. Interest income is recorded on the accrual basis, adjusted for amortization of premiums and accretion of discounts. Dividend income is recorded on the ex-dividend date, less any foreign taxes withheld. Upon notification from issuers, some of the dividend income received may be redesignated as a reduction of cost of the related investment if it represents a return of capital.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The aggregate cost of purchases and proceeds from sales of investment securities (other than short-term investments) for the six months ended March 31, 2021 totaled $198,793,275 and $208,795,489, respectively.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Repurchase Agreements</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In managing short-term investments the Fund may from time to time enter into transactions in repurchase agreements. In a repurchase agreement, the Fund's custodian takes possession of the underlying collateral securities from the counterparty, the market value of which is at least equal to the principal, including accrued interest, of the repurchase transaction at all times. In the event of default or bankruptcy by the other party to the agreement, realization and/or retention of the collateral by the Fund may be delayed. The Fund may enter into repurchase transactions with any broker, dealer, registered clearing agency or </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>22</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=24,FOLIO='22',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">bank. Repurchase agreement transactions are not counted for purposes of the limitations imposed on the Fund's investment in debt securities.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Distribution Policy</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Pursuant to a Securities and Exchange Commission exemptive order, the Fund may make periodic distributions that include capital gains as frequently as 12 times in any one taxable year in respect of its common shares, and the Fund has implemented a managed distribution policy (the Policy) providing for quarterly distributions at a rate set by the Trustees. Under the current Policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Fund intends to use net realized capital gains when making quarterly distributions, if available, but the Policy would result in a return of capital to shareholders if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. If taxable income and net long-term realized gains exceed the amount required to be distributed under the Policy, the Fund will at a minimum make distributions necessary to comply with the requirements of the Internal Revenue Code. The Policy has been established by the Trustees and may be changed by them without shareholder approval. The Trustees regularly review the Policy and the frequency and rate of distribution considering the purpose and effect of the Policy, the financial market environment, and the Fund's income, capital gains and capital available to pay distributions.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's policy is to declare quarterly distributions in stock. The distributions are automatically paid in newly-issued full shares of the Fund unless otherwise instructed by the shareholder. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts of the Fund's transfer agent who will have whole and fractional shares added to their accounts. The Fund's transfer agent delivers an election card and instructions to each registered shareholder in connection with each distribution. The number of shares issued will be determined by dividing the dollar amount of the distribution by the lower of net asset value or market price on the pricing date. If a shareholder elects to receive a distribution in cash, rather than in shares, the shareholder's relative ownership in the Fund will be reduced. The shares reinvested will be valued at the lower of the net asset value or market price on the pricing date. Distributions in stock will not relieve shareholders of any federal, state or local income taxes that may be payable on such distributions. Additional distributions, if any, made to satisfy requirements of the Internal Revenue Code may be paid in stock, as described above, or in cash.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>23</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=25,FOLIO='23',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Share Repurchase Program</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In March 2021, the Trustees approved the renewal of the repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares in the open market for a one-year period ending July 14, 2022. Prior to this renewal, in March 2020, the Trustees approved the renewal of the share repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares for a one-year period ending July 14, 2021. The share repurchase program is intended to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the Fund's net asset value.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">During the six months ended March 31, 2021, the Fund did not repurchase any shares through the repurchase program.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">During the year ended September 30, 2020, the Fund repurchased 136,700 shares at a total cost of $2,191,362. The weighted average discount per share between the cost of repurchase and the net asset value applicable to such shares at the date of repurchase was 11.70%.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Federal Taxes</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">It is the Fund's policy to comply with the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute to its shareholders substantially all of its taxable income and its net realized capital gains, if any. Therefore, no Federal income or excise tax provision is required.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">As of March 31, 2021, the Fund had no uncertain tax positions that would require financial statement recognition or disclosure. The Fund's federal tax returns are subject to examination by the Internal Revenue Service for a period of three years.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Distributions</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund records all distributions to shareholders on the ex-dividend date. Such distributions are determined in conformity with income tax regulations, which may differ from GAAP. These differences include temporary and permanent differences from losses on wash sale transactions, passive foreign investment companies transactions, installment sale adjustments, premium amortization accruals, foreign currency gains and losses, book to tax difference due to merger and ordinary loss netting to reduce short term capital gains. Reclassifications are made to the Fund's capital accounts to reflect income and gains available for distribution under income tax regulations.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>24</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=26,FOLIO='24',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Commitments and Contingencies</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Under the Fund's organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The Fund's maximum exposure under these agreements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred. However, based on experience, the Fund expects the risk of loss to be remote.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Investor Support Services</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund has retained Destra Capital Advisors LLC (Destra) to provide investor support services in connection with the ongoing operation of the Fund. The Fund pays Destra a fee in an annual amount equal to 0.05% of the average aggregate daily value of the Fund's Managed Assets pursuant to the investor support services agreement.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>New Accounting Pronouncement</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In October 2020, the SEC adopted new regulations governing the use of derivatives by registered investment companies. Rule 18f-4 will impose limits on the amount of derivatives a fund could enter into, eliminate the asset segregation framework currently used by funds to comply with Section 18 of the 1940 Act, and require funds whose use of derivatives is more than a limited specified exposure to establish and maintain a derivatives risk management program and appoint a derivatives risk manager. While the new rule became effective February 19, 2021, funds will not be required to fully comply with the new rule until August 19, 2022. It is not currently clear what impact, if any, the new rule will have on the availability, liquidity or performance of derivatives. When fully implemented, the new rule may require changes in how a fund will use derivatives, may adversely affect a fund's performance and may increase costs related to a fund's use of derivatives.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>(2)&nbsp;&nbsp;Investment Advisory and Other Affiliated Fees</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund has entered into an Investment Advisory Agreement (the Advisory Agreement) with the Adviser. Pursuant to the terms of the Advisory Agreement, the Fund pays the Adviser a monthly fee at the rate when annualized of (i) 2.50% of the average net assets for the month of its venture capital and other restricted securities up to 25% of net assets and (ii) for all other net assets, 0.98% of the average net assets up to $250 million, 0.88% of the average net assets for the next $250 million, 0.80% of the average net assets for the next </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>25</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=27,FOLIO='25',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$500 million and 0.70% of the average net assets thereafter. The aggregate fee would not exceed a rate when annualized of 1.36%.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund has entered into a Services Agreement (the Agreement) with the Adviser. Pursuant to the terms of the Agreement, the Fund reimburses the Adviser for certain services related to a portion of the payment of salary and provision of benefits to the Fund's Chief Compliance Officer. During the six months ended March 31, 2021, these payments amounted to $27,801 and are included in the Other category of expenses in the Statement of Operations, together with insurance and other expenses incurred to unaffiliated entities. Expenses incurred pursuant to the Agreement as well as certain expenses paid for by the Adviser are allocated to the Fund in an equitable fashion as approved by the Trustees or officers of the Fund who are also officers of the Adviser.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund pays compensation to Independent Trustees in the form of a retainer, attendance fees, and additional compensation to Board and Committee chairpersons. The Fund does not pay compensation directly to Trustees or officers of the Fund who are also officers of the Adviser.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>(3)&nbsp;&nbsp;Fair Value Measurements</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund uses a three-tier hierarchy to prioritize the assumptions, referred to as inputs, used in valuation techniques to measure fair value. The three-tier hierarchy of inputs is summarized in the three broad levels. Level 1 includes quoted prices in active markets for identical investments. Level 2 includes prices determined using other significant observable inputs (including quoted prices for similar investments, interest rates, credit risk, etc.). The independent pricing vendor may value bank loans and debt securities at an evaluated bid price by employing methodologies that utilize actual market transactions, broker-supplied valuations, and/or other methodologies designed to identify the market value for such securities and such securities are considered Level 2 in the fair value hierarchy. Level 3 includes prices determined using significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). These inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">For the period ended March 31, 2021, there were no transfers between levels.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>26</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=28,FOLIO='26',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The following is a summary of the levels used as of March 31, 2021 to value the Fund's net assets.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="130" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Assets at Value</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 1</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 2</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="74" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="455" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Preferred</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">19,032,033</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">19,032,033</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,397,369</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,397,369</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="455" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common Stocks and Warrants</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">361,391,268</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">305,144</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">361,696,412</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">13,448,173</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,429,690</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">14,877,863</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Providers &amp; Services</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">955,099</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">70,415</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,025,514</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Healthcare Services</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,907,660</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,907,660</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Life Sciences Tools &amp; Services</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">38,162,078</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">38,162,078</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">47,785,444</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,844</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,685</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">47,795,973</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Special Purpose Acquisition Company</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">802,455</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">802,455</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Short-term Investment</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,047,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,047,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="455" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone Interests</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">585,481</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">585,481</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,727</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,727</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,866,329</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,866,329</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">80,325</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">80,325</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="130" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">469,452,177</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,049,844</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">32,776,197</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">503,278,218</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Investment in <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="86" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance as of <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2020</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="100" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">gain (loss) and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">change in<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">unrealized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">appreciation<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(depreciation)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">purchases<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="91" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Proceeds<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">sales and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">transfers<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">into<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(out of)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="87" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">as of <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">March 31, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2021</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="614" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Preferred</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15,928,255</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,694,461</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,807,540</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9,398,223</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">19,032,033</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,397,369</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,397,369</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="614" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Notes</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">295,378</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(195,698</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(99,680</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="614" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common Stocks and Warrants</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">329,220</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(24,731</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">655</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">305,144</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,331,737</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">97,953</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,429,690</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Providers &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Services</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">105,467</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3,452</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(31,600</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">70,415</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">49,631</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(41,946</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,685</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>27</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=29,FOLIO='27',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Investment in <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="86" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance as of <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2020</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="100" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">gain (loss) and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">change in<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">unrealized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">appreciation<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(depreciation)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">purchases<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="91" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Proceeds<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">sales and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">transfers<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">into<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(out of)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="87" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">as of <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">March 31, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2021</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="614" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone Interests</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,515,794</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">538,205</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">392,108</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">585,481</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,407</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1,680</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,727</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,711,391</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(845,062</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,866,329</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">91,662</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">79,754</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(91,091</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">80,325</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">31,759,310</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,141,640</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,887,949</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10,012,702</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">32,776,197</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="519" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net change in unrealized appreciation (depreciation) from <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">investments still held as of March 31, 2021</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,268,010</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The following is a quantitative disclosure about significant unobservable inputs used in the determination of the fair value of Level 3 assets.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="62" valign="bottom" style="padding:6pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="82" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Fair Value at <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">March 31, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2021</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="77" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Valuation Technique</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Unobservable Input</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="110" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Range<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(Weighted Average)</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="62" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common Stock<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and Warrants</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,446,131<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="77" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Income approach,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Black-Scholes</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="93" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Discount for lack of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">marketability</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="94" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00%-50.00% (20.33%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">  &nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="62" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="top" style="padding:2pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="55" align="right" valign="top" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">70,415 <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" valign="top" style="padding:2pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="77" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00% (20.00%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> 1.75-2.75 (2.25) years</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="62" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">296,388 </font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="77" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Market approach</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="77" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="94" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">N/A</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="62" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Preferred</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="top" style="padding:2pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="55" align="right" valign="top" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">172,629<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" valign="top" style="padding:2pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="77" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00% (20.00%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> 0.25 (0.25) years</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="62" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10,313,094</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="77" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Market approach</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="77" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="94" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">N/A</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="62" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12,943,678</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="77" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Recent transaction</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="77" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(b)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">N/A</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="62" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Interests</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="top" style="padding:2pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="top" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,453,537<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:2pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="77" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="93" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="94" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00%-100.00% (70.72%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> 0.25-16.00 (4.03) years</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="62" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">80,325</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="77" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00%-95.00% (20.54%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> 0.50-6.75 (0.54) years</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="62" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">32,776,197</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="77" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="93" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="110" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)&nbsp;&nbsp;There is no quantitative information to provide as these methods of measure are investment specific.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(b)&nbsp;&nbsp;The valuation technique used as a basis to approximate fair value of these investments is based upon subsequent financing rounds.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>(4)&nbsp;&nbsp;Private Companies and Other Restricted Securities</i></font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund may invest in private companies and other restricted securities if these securities would currently comprise 40% or less of net assets. The value of these securities represented 7% of the Fund's net assets at March 31, 2021.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>28</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=30,FOLIO='28',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>MARCH 31, 2021</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">At March 31, 2021, the Fund had commitments of $3,510,552 relating to additional investments in three private companies.</font></p>
<p style="margin:0pt 0pt 8pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The following table details the acquisition date, cost, carrying value per unit, and value of the Fund's private companies and other restricted securities at March 31, 2021. The Fund on its own does not have the right to demand that such securities be registered.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Security (#)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Acquisition<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="74" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="99" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Carrying Value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">per Unit</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="74" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Value</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Afferent Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/27/16</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">161,872</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">291,920.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">291,920</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="484" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Amphivena Therapeutics, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/17/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,101,250</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,100,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/10/18</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">808,893</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.59</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">808,848</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Arkuda Therapeutics, Inc. Series A Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">05/16/19, 04/02/20</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,018,184</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.38</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,018,184</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Caribou Biosciences, Inc. Series C Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/01/21</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,366,239</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">17.26</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,365,012</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cercacor Laboratories, Inc. Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/31/98&dagger;</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,429,690</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Curasen Therapeutics, Inc. Series A Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">09/18/18, 01/07/20</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.10</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Dynacure Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">04/21/20, 10/28/20</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,468,910</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">24.88</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,579,921</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Ethismos Research Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10/31/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Hotspot Therapeutics, Inc. Series B Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">04/22/20</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,550,002</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.40</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,550,002</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Impact Biomedicines Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/20/10</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,290,972.00</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,290,972</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">InnovaCare, Inc. Escrow Shares Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/21/12&dagger;</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">64,073</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.48</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">70,415</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Invetx, Inc. Series A Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">08/06/20</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,550,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.48</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,550,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">IO Light Holdings, Inc. Series A2 Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">04/30/20&dagger;</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,394,759</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.85</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,397,369</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Neurovance Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/20/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,417,500</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,283,437.00</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,283,437</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Oculis SA Series B2 Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">01/16/19</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">990,902</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8.81</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,036,876</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Priothera Ltd. Series A Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10/07/20</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">483,215</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11.73</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">481,593</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pyxis Oncology, Inc. Series B Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/05/21</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,921,726</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.65</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,920,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="484" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Rainier Therapeutics, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series A Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">01/19/16, 10/24/16</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">750,652</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&dagger;&dagger;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">115</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/03/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">500,091</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.19</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">124,332</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Rallybio Holdings, LLC Series B Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/27/20</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,105,343</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.39</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,100,044</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Therachon Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/01/19</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,017,671</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">585,481.00</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">585,481</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Therox Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">06/18/19</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,082</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,727.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,727</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="484" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Vectivbio Holding AG</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/01/19&dagger;</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">293,249</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.79</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">296,250</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series A2 Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">09/02/20</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">397,678</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.15</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">397,106</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" valign="bottom" style="padding:7.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" valign="bottom" style="padding:7.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:7.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:7.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">29,367,290</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:7.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="99" bgcolor="#cceeff" valign="bottom" style="padding:7.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:7.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:7.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">32,679,293</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:7.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&nbsp;&nbsp;(#)&nbsp;&nbsp;See Schedule of Investments and corresponding footnotes for more information on each issuer.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&nbsp;&nbsp;&dagger;&nbsp;&nbsp;Interest received as part of a corporate action for a previously owned security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&nbsp;&nbsp;&dagger;&dagger;&nbsp;&nbsp;Carrying value per unit is greater than $0.00 but less than $0.01.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>29</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=31,FOLIO='29',FILE='21-3429-2.fa.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>

<!-- Document name: 21-3429-2.ga-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT ADVISORY AGREEMENT APPROVAL</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Investment Advisory Agreement (the Advisory Agreement) between the Fund and the Adviser continues in effect so long as its continuance is approved at least annually by (i) the Trustees of the Fund and (ii) a majority of the Trustees of the Fund who are not interested persons (the Independent Trustees), by vote cast in person at a meeting called for the purpose of voting on such approval.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">After considering the matter in a meeting held on March 18, 2021, the Board, and the Independent Trustees voting separately, determined that the terms of the Advisory Agreement are fair and reasonable and approved the continuance of the Advisory Agreement as being in the best interests of the Fund and its shareholders. In making its determination, the Board considered materials that were specifically prepared by the Adviser and by an independent data provider at the request of the Board and Fund counsel for purposes of the contract review process, including comparisons of (i) the Fund's performance both directly and on a risk adjusted basis to a benchmark, the NASDAQ Biotech Index<sup>&reg;</sup> (NBI), and to a peer universe of other investment companies, (ii) the Fund's expenses and expense ratios to those of a peer group of other investment companies, and (iii) the Adviser's profitability with respect to its services for the Fund to the profitability of other investment advisers. The Trustees took into account that substantially all of the Adviser's business consists of providing investment management services to Tekla Life Sciences Investors, Tekla Healthcare Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund and the Adviser does not derive any significant benefit from its relationship with the Fund other than receipt of advisory fees pursuant to the Advisory Agreement, market research and potential marketing exposure for the Adviser. The Board also received and reviewed information throughout the year about the portfolio performance, the investment strategy, the portfolio management team and various fees and expenses of the Fund. In their deliberations, the Independent Trustees had the opportunity to meet privately without representatives of the Adviser present and were represented throughout the process by counsel to the Independent Trustees and the Fund.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In approving the Advisory Agreement, the Board considered, among other things, the nature, extent, and quality of the services to be provided by the Adviser, the investment performance of the Fund and the Adviser, the costs of services provided and profits realized by the Adviser and its affiliates, and whether fee levels reflect any economies of scale for the benefit of Fund shareholders and the extent to which economies of scale would be realized as the Fund grows. The Board reviewed information about the foregoing factors and </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>30</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=32,FOLIO='30',FILE='21-3429-2.ga.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT ADVISORY AGREEMENT APPROVAL</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">considered changes, if any, in such information since its previous approval. The Board also evaluated the financial strength of the Adviser and the capability of the personnel of the Adviser, specifically the strength and background of its investment analysts. Fund counsel provided the Board with the statutory and regulatory requirements for approval and disclosure of investment advisory agreements. The Board, including the Independent Trustees, evaluated all of the foregoing and, considering all factors together, determined in the exercise of its business judgment that the continuance of the Advisory Agreement is in the best interests of the Fund and its shareholders. The following provides more detail on certain factors considered by the Trustees and the Board's conclusions with respect to each such factor.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><u>The nature, extent and quality of the services to be provided by the Adviser. </u>On a regular basis the Board considers the roles and responsibilities of the Adviser as a whole, along with specific portfolio management, support and trading functions the Adviser provides to the Fund. The Trustees considered the nature, extent and quality of the services provided by the Adviser to the Fund. The Trustees continue to be satisfied with the quality and value of the investment advisory services provided to the Fund by the Adviser, and, in particular, the management style and discipline followed by the Adviser and the quality of the Adviser's research, trading, portfolio management, compliance and administrative personnel. The Trustees also took into account the Adviser's significant investment in its business through the addition of portfolio management and administrative staff over the last several years and the Adviser's commitment to continue to build out its infrastructure as future circumstances require.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><u>The investment performance of the Fund and the Adviser.</u> On a regular basis the Board reviews performance information of the Fund and discusses the Fund's investment strategy with the Adviser. The Trustees reviewed performance information for the Fund for the past one-, three-, five- and ten-year periods ended December 31, 2020, as compared to its benchmark, the NBI, and a peer universe of other investment companies identified by an independent service provider engaged by the Independent Trustees. The Trustees noted that the performance information reviewed reflects a view of the Fund's performance only as of a certain date, and that the results might be significantly different if a different date was selected to generate the performance information. Additionally, the Trustees recognized that longer periods of performance for the Fund may be adversely and disproportionately affected by significant underperformance in one more recent period, and that such underperformance may be caused by a small number of investment decisions or positions.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>31</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=33,FOLIO='31',FILE='21-3429-2.ga.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT ADVISORY AGREEMENT APPROVAL</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Unlike many other broader-based healthcare indices, the NBI contains high levels of biotechnology-based companies. Over time, this index has demonstrated higher returns, but has also demonstrated higher price volatility than the broad S&amp;P 500<sup>&reg;</sup> Index. The Adviser seeks to operate the Fund at a biotechnology exposure level that is higher than many other indices and Funds but at a level that is below that of the NBI. The Adviser also seeks to operate the Fund at lower volatility than that of the NBI. In the current reporting period, the Adviser sought to do so by limiting exposure to biotechnology relative to the NBI and also by maintaining a higher exposure to large biotechnology companies (which exhibit relatively lower volatility) than is present in the NBI and lower exposure to small and mid-capitalization biotechnology companies than is present in the NBI.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Trustees noted the Fund's strong absolute performance. In particular, the Trustees noted that on a net asset value basis as of December 31, 2020, the Fund returned 21.77% for the one-year period and had annualized returns of 12.28% for the three-year period, 7.12% for the five-year period, and 15.94% for the ten-year period. The Trustees also noted that on a net asset value basis, as of December 31, 2020, the Fund outperformed the NBI for the five-year period, slightly underperformed the NBI for the three-year period, and underperformed the NBI for the one- and ten-year periods. The Trustees also noted that the Fund exhibited lower volatility than the NBI for all evaluation periods and outperformed the NBI on a risk adjusted basis for the three- and five-year periods ended December 31, 2020. The Trustees noted that as of December 31, 2020, the Fund outperformed the peer universe average for the 10-year period, slightly underperformed the peer universe average for the one-year period and underperformed the peer universe average for the three- and five-year periods.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In considering the Fund's relative performance, the Trustees recognized that the Fund's unique strategy presents challenges when comparing the Fund's performance to a benchmark or group of comparable funds. In particular, the Trustees observed that the Fund's strategy has historically included a lower biotechnology allocation compared to the NBI and a higher biotechnology allocation compared to many other healthcare indices and to many of the other funds in the peer universe. The Trustees noted that, as a result, all other things being equal, in periods when biotechnology performs relatively well, the Fund might be expected to underperform the NBI (and/or the peer universe) and vice versa. Additionally, the Trustees noted that unlike the NBI and most of the peer universe, the Fund often maintains a meaningful allocation to venture </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>32</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=34,FOLIO='32',FILE='21-3429-2.ga.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT ADVISORY AGREEMENT APPROVAL</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">and restricted securities. In light of these differences, the Trustees recognized the more limited usefulness of these performance comparisons for the Fund.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Trustees concluded they continue to be satisfied with the investment performance of the Fund and the Adviser.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><u>The costs of services to be provided and profits to be realized by the Adviser from its relationship with the Fund.</u> The Trustees considered the various services provided by the Adviser to the Fund and reviewed comparative information regarding the expenses and expense ratios of the Fund and a peer group of other investment companies identified by an independent service provider engaged by the Independent Trustees. The Trustees noted that the Adviser's fees are within the range of fees presented in the comparative information and noted that the Fund often maintains a meaningful allocation to venture and restricted securities, a portfolio management service that can warrant higher management fees than those charged by the Adviser to the Fund. The Trustees also considered financial information provided by the Adviser, including financial statements of the Adviser and a comparison of the Adviser's profitability with respect to its services for the Fund to the profitability of other investment advisers.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Trustees noted that the fees charged by the Adviser are within a reasonable range of fees as compared to fees charged by other investment advisers for similar services, and the services provided by the Adviser and the amounts paid under the Advisory Agreement are at least comparable to the services rendered and fees charged by others for similar services to warrant a finding that fees to be paid by the Fund are fair. Based on the information provided to and evaluated by the Trustees, the Trustees concluded that the fees charged by the Adviser are fair and reasonable in light of the quality and nature of the services provided by the Adviser and that the profitability of the Adviser's relationship with the Fund has not been excessive.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><u>Whether fee levels reflect economies of scale and the extent to which economies of scale would be realized as the Fund grows.</u> The Trustees considered the advisory fee schedule in the Advisory Agreement and noted that it provides for breakpoints that would reduce the effective fee to the extent the Fund's net assets should increase, allowing the Fund to share in the benefits of any economies of scale that would inure to the Adviser as the Fund's assets increase. Given the closed-end structure of the Fund, its current asset size, and the fact that any economies of scale are modest at current Fund asset levels, the Trustees determined that the Fund's advisory fee schedule is satisfactory and fair.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>33</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=35,FOLIO='33',FILE='21-3429-2.ga.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>PRIVACY NOTICE:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> If you are a registered shareholder of the Fund, the Fund and Tekla Capital Management LLC, the Fund's investment adviser, may receive nonpublic personal information about you from the information collected by the transfer agent from your transactions in Fund shares. Any nonpublic personal information is not disclosed to third parties, except as permitted or required by law. In connection with servicing your account and effecting transactions, the information received may be shared with the investment adviser and non-affiliates, including transfer agents, custodians or other service companies. Access to your nonpublic personal information is restricted to employees who need to know that information to provide products or services to you. To maintain the security of your nonpublic personal information, physical, electronic, and procedural safeguards are in place that comply with federal standards. The policies and practices described above apply to both current and former shareholders.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">If your Fund shares are held in "street name" at a bank or brokerage, we do not have access to your personal information and you should refer to your bank's or broker's privacy policies for a statement of the treatment of your personal information.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>FOR MORE INFORMATION:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> A description of the Fund's proxy voting policies and procedures and information on how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available (i) without charge, upon request by calling 1-800-451-2597; (ii) by writing to Tekla Capital Management LLC at 100 Federal Street, 19th Floor, Boston, MA 02110; (iii) on the Fund's website at www.teklacap.com; and (iv) on the SEC's website at www.sec.gov.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's complete Schedule of Investments for the first and third quarters of its fiscal year will be filed with the SEC on Form N-PORT. This Schedule of Investments will also be available on the Fund's website at www.teklacap.com or the SEC's website at www.sec.gov.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">You can find information regarding the Fund at the Fund's website, www.teklacap.com. The Fund regularly posts information to its website, including information regarding daily share pricing, distributions, press releases and links to the Fund's SEC filings. The Fund currently publishes and distributes quarterly fact cards, which include performance, portfolio holdings and sector information for each fiscal quarter. These fact cards will be available on the Fund's website and by request from the Fund's marketing and investor support services agent, Destra Capital Advisors LLC, at 1-877-855-3434.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>34</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=36,FOLIO='34',FILE='21-3429-2.ga.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>DISTRIBUTION POLICY:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> The Fund has a fixed distribution policy as described in the Notes to Financial Statements. For more information contact your financial adviser.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>SHARE REPURCHASE PROGRAM:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> In March 2021, the Trustees reauthorized the share repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares for a one-year period ending July 14, 2022.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>PORTFOLIO MANAGEMENT:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> Daniel R. Omstead, Ph.D., Jason C. Akus, M.D./M.B.A., Timothy Gasperoni, M.B.A., Ph.D., Ashton L. Wilson, Christopher Abbott, Robert Benson, Richard Goss, Jack Liu, M.B.A., Ph.D., and Loretta Tse, Ph.D. are members of a team that analyzes investments on behalf of the Fund. Dr. Omstead exercises ultimate decision making authority with respect to investments.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>HOUSEHOLDING:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> A number of banks, brokers and financial advisers have instituted "householding". Under this practice, which has been approved by the SEC, only one copy of shareholder documents may be delivered to multiple shareholders who share the same address and satisfy other conditions. Householding is intended to reduce expenses and eliminate duplicate mailings of shareholder documents. If you do not want the mailing of your shareholder documents to be combined with those of other members of your household, please contact your bank, broker or financial adviser.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>35</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=37,FOLIO='35',FILE='21-3429-2.ga.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>

<!-- Document name: 21-3429-2.za-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:16pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:7pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">New York Stock Exchange Symbol: HQL<BR>NAV Symbol: XHQLX</font></p>
<p style="margin:7pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">100 Federal Street, 19th Floor<BR>Boston, Massachusetts 02110<BR>(617) 772-8500<BR>www.teklacap.com</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Officers</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead, Ph.D., President<BR>Laura Woodward, CPA, Chief Compliance Officer,<BR>Secretary and Treasurer</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Trustees</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Jeffrey A. Bailey<BR>Rakesh K. Jain, Ph.D.<BR>Thomas M. Kent, CPA<BR>Daniel R. Omstead, Ph.D.<BR>Oleg M. Pohotsky, M.B.A., J.D.<BR>William S. Reardon, M.B.A.<BR>Lucinda H. Stebbins, M.B.A.</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Investment Adviser</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tekla Capital Management LLC</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Administrator &amp; Custodian</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">State Street Bank and Trust Company</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Transfer Agent</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Computershare, Inc.</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Legal Counsel</b></font></p>
<p style="margin:0pt 0pt 11pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dechert LLP</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholders with questions regarding share transfers may call</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:14pt;"><b>1-800-426-5523</b></font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daily net asset value may be obtained from<BR>our website (</font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>www.teklacap.com</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">) or by calling</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:14pt;"><b>617-772-8500</b></font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=38,FOLIO='',FILE='21-3429-2.za.qxp',USER='Unknown',CD='May 25 22:41 2021' -->
<div style="page-break-before:always"></div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 2. CODE OF ETHICS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable to this semi-annual filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable to this semi-annual filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable to this semi-annual filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable to this semi-annual filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 6. INVESTMENTS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Registrant&#8217;s Schedule of Investments
is included as part of the Report to Shareholders filed under Item 1 of this form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES
FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable to this semi-annual filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT
COMPANIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable to this semi-annual filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 9. PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT
INVESTMENT COMPANY AND AFFILIATED PURCHASERS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Period</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(a)&nbsp;Total&nbsp;No.<BR> of&nbsp;Shares<BR> Purchased&nbsp;(1)</TD><TD STYLE="padding-left: 1pt; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(b)&nbsp;Average<BR> Price&nbsp;Paid&nbsp;per<BR> Share</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(c)&nbsp;Total&nbsp;No.<BR> of&nbsp;Shares<BR> Purchased&nbsp;as<BR> Part&nbsp;of<BR> Publicly<BR> Announced&nbsp;Plans<BR> or&nbsp;Programs</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(d)&nbsp;Maximum&nbsp;No.<BR> of&nbsp;Shares&nbsp;that<BR> May&nbsp;Yet&nbsp;Be<BR> Purchased&nbsp;Under<BR> the&nbsp;Plans&nbsp;or<BR> Programs</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font: bold 10pt Times New Roman, Times, Serif">Month #1 (Oct.&nbsp;1, 2020 - Oct.&nbsp;31, 2020 )</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">12,125 </TD><TD STYLE="padding-left: 1pt; width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">(2)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">17.63</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">2,839,946</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Month #2 (Nov.&nbsp;1, 2020  &mdash; Nov.&nbsp;30, 2020 )</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-left: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,839,946</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Month #3 (Dec.&nbsp;1, 2020 &mdash; Dec 31.&nbsp;2020 )</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-left: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,839,946</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Month #4 (Jan.&nbsp;1, 2021 &mdash; Jan.&nbsp;31, 2021)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-left: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,839,946</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Month #5 (Feb.&nbsp;1, 2021 &mdash; Feb.&nbsp;28, 2021)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-left: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,839,946</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Month #6 (Mar.&nbsp;1, 2021 &mdash; Mar.&nbsp;31, 2021)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-left: 1pt; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,839,946</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,125</TD><TD STYLE="padding-left: 1pt; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17.63</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD>On June&nbsp;30, 2011, the share repurchase program was announced, which has been subsequently reviewed and approved by the
Board of Trustees. On March&nbsp;19, 2020, the share repurchase program was renewed, allowing the Registrant to repurchase up to
12% of its outstanding shares for a one year period ending July&nbsp;14, 2021. On March&nbsp;18, 2021, the Trustees approved the
renewal of the repurchase program to allow the Registrant to repurchase up to 12% of its outstanding shares in the open market
for a one year period ending July&nbsp;14, 2022.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD>12,125 shares were purchased in Month #1 by Daniel R. Omstead in the open market. Dr. Omstead is a director of the Registrant
and a controlling person of the Registrant's investment adviser.&nbsp; Accordingly, Dr. Omstead may be deemed an &quot;affiliated
purchaser&quot; of the Registrant's shares as such term is defined by Rule 10b-18(a)(3) under the Exchange Act of 1934.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There have been no material changes to the procedures by which
the shareholders may recommend nominees to the Registrant&#8217;s Board of Trustees, where those changes were implemented after
the Registrant last provided disclosure in response to the requirements of Item 7(d)(2)(ii)(G)&nbsp;of Schedule 14A, or this Item.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 11. CONTROLS AND PROCEDURES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD>In the opinion of the principal executive officer and principal financial officer, based on their evaluation which took place
within 90 days of this filing, the Registrant&#8217;s disclosure controls and procedures are adequately designed and are operating
effectively to ensure (i)&nbsp;that material information relating to the Registrant, including its consolidated subsidiaries, is
made known to them by others within those entities, particularly during the period in which this report is being prepared; and
(ii)&nbsp;that information required to be disclosed by the registrant on Form&nbsp;N-CSR is recorded, processed, summarized and
reported within the time period specified in the Securities and Exchange Commission&#8217;s rules&nbsp;and forms.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD>There were no changes in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s
most recent second fiscal quarter that have materially affected or that are reasonably likely to materially affect the Registrant&#8217;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Item 12. Disclosure
of Securities Lending Activities for Closed-End Management Investment Companies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 13. EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(1)&nbsp;&nbsp;Code
of Ethics - </FONT>Not applicable to this semi-annual filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><A HREF="tm213429d1_ex99cert.htm">(a)(2)&nbsp;Separate certifications of the Principal Executive and Financial Officers as required by Rule&nbsp;30a-2(a)&nbsp;under the 1940Act and Section&nbsp;302 of the Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit&nbsp;1 and 2).</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><A HREF="tm213429d1_ex99section19a.htm">(a)(3)&nbsp;Notices to Fund&#8217;s shareholders in accordance with Investment Company Act Section&nbsp;19(a)&nbsp;and Rule&nbsp;19a-1 (Exhibit&nbsp;3).</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><A HREF="tm213429d1_ex99-906cert.htm">(b)&nbsp;Certifications pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit&nbsp;4).</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">Pursuant to the requirements of the Securities
Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TEKLA LIFE SCIENCES INVESTORS</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By (Signature and Title)*</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Daniel R. Omstead</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel R. Omstead, President</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid">6/4/21</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD STYLE="width: 28%">&nbsp;</TD>
    <TD STYLE="width: 51%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">Pursuant to the requirements of the Securities
Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf
of the registrant and in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By (Signature and Title)*</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Laura Woodward</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laura Woodward, Treasurer</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">6/4/21</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 18%">&nbsp;</TD>
    <TD STYLE="width: 28%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Print the name and title of each signing officer under his
or her signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CERT
<SEQUENCE>2
<FILENAME>tm213429d1_ex99cert.htm
<DESCRIPTION>EXHIBIT 99.CERT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.CERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;1: CERTIFICATION OF PRINCIPAL
EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I,&nbsp;&nbsp;&nbsp;Daniel R. Omstead, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD>I have reviewed this report on Form&nbsp;N-CSR of TEKLA LIFE SCIENCES INVESTORS;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in
all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements
are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD>The registrant&#8217;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Rule&nbsp;30a-3(c)&nbsp;under the Investment Company Act of 1940) and internal control over financial
reporting (as defined in Rule&nbsp;30a-3(d)&nbsp;under the Investment Company Act of 1940) for the Registrant and have:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD>Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this
report based on such evaluation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD>Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during
the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s
internal control over financial reporting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD>The registrant&#8217;s other certifying officer(s)&nbsp;and I have disclosed to the registrant&#8217;s auditors and the audit
committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize, and report financial
information; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 43%">6/4/21</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Daniel R. Omstead</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Daniel R. Omstead</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;2: CERTIFICATION OF PRINCIPAL
FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I,&nbsp;&nbsp;&nbsp;Laura Woodward, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD>I have reviewed this report on Form&nbsp;N-CSR of TEKLA LIFE SCIENCES INVESTORS;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in
all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements
are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD>The registrant&#8217;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Rule&nbsp;30a-3(c)&nbsp;under the Investment Company Act of 1940) and internal control over financial
reporting (as defined in Rule&nbsp;30a-3(d)&nbsp;under the Investment Company Act of 1940) for the Registrant and have:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD>Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this
report based on such evaluation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD>Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during
the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s
internal control over financial reporting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD>The registrant&#8217;s other certifying officer(s)&nbsp;and I have disclosed to the registrant&#8217;s auditors and the audit
committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize, and report financial
information; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid">6/4/21</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Laura Woodward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Laura Woodward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Treasurer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>






<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.SECTION19(A)
<SEQUENCE>3
<FILENAME>tm213429d1_ex99section19a.htm
<DESCRIPTION>EXHIBIT 99.SECTION19(A)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.Section 19(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT 3: SECTION&nbsp;19(a) NOTICE
TO FUND&#8217;S SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 18pt">T</FONT><FONT STYLE="font-size: 14pt">EKLA
LIFE SCIENCES INVESTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Notification of Sources of Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Distribution Paid Date: &nbsp;&nbsp;December 31, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Distribution Amount Per Common Share: &nbsp;&nbsp;$0.40</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth the estimated amounts of the
current distribution, paid December 31, 2020, and the cumulative distributions paid this fiscal year-to-date from the following sources:
net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital
source. All amounts are expressed per common share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Breakdown of the</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Breakdown</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total Cumulative</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total Cumulative</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt"><B>Current</B></TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">of Current</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Distributions for the</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Distributions for the</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Distribution</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Distribution</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fiscal Year to Date<SUP>1</SUP></B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fiscal Year to Date<SUP>1</SUP></B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: left; padding-bottom: 1pt">Net Investment Income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 10%; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 10%; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 15%; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 15%; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net Realized ST Cap Gains</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">0.3900</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">98</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">0.3900</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">98</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net Realized LT Cap Gains</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">0.0100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">2</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">0.0100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">2</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Return of Capital or Other Capital Source</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">TOTAL (per common share):</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.4000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.4000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table below includes information relating to the Fund&rsquo;s
performance based on its NAV for certain periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 87%; text-align: left; padding-bottom: 1pt">Average annual total return at NAV for the period from October 31, 2015 through October 31, 2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 10%; text-align: right">4.97</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Annualized current distribution rate expressed as a percentage of NAV as of October 31, 2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">8.21</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative total return at NAV for the fiscal year, through October 31, 2020<SUP>2</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-3.07</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of October 31, 2020<SUP>1</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">2.05</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You should not draw any conclusions about the Fund&rsquo;s
investment performance from the amount of this distribution or from the terms of the Fund&rsquo;s managed distribution policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The composition of this and subsequent distribution may vary from
quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized
appreciation of portfolio securities and net realized gains on sale of securities is $180,403,667, of which $177,263,254 represents net
unrealized appreciation of portfolio securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The amounts and sources of distributions reported in this
19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for
tax reporting purposes will depend upon the Fund&rsquo;s investment experience during the remainder of its fiscal year and may be subject
to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these
distributions for federal income tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP>The Fund&rsquo;s current fiscal year began on
October 1, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP>Cumulative total return at NAV
is the percentage change in the Fund&rsquo;s NAV and includes all distributions and assumes the reinvestment of those distributions for
the period of September 30, 2020 through October 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tekla Life Sciences Investors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CUSIP: 87911K100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">www.teklacap.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tekla Capital Management LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 Federal Street, 19<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boston, Massachusetts 02110</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">617-772-8500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fax: 617-772-8577</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">03D6DB&#9;002CSNB5ED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 18pt">T</FONT><FONT STYLE="font-size: 14pt">EKLA
LIFE SCIENCES INVESTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Notification of Sources of Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Distribution Paid Date: &nbsp;&nbsp;January 6, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Distribution Amount Per Common Share: &nbsp;&nbsp;$0.02</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth the estimated
amounts of the current distribution, paid January 6, 2021, and the cumulative distributions paid this fiscal year-to-date from the following
sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other
capital source. All amounts are expressed per common share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom"><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Breakdown of the</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Breakdown</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total Cumulative</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total Cumulative</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Current</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">of Current</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Distributions for the</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Distributions for the</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Distribution</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Distribution</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fiscal Year to Date<SUP>1</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fiscal Year to Date<SUP>1</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 38%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net Investment Income</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net Realized ST Cap Gains</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">0.3900</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">93</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net Realized LT Cap Gains</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0200</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0300</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">7</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Return of Capital or Other Capital Source</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">TOTAL (per common share):</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0200</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.4200</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table below includes information relating to the Fund&rsquo;s
performance based on its NAV for certain periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 87%; text-align: left; padding-bottom: 1pt">Average annual total return at NAV for the period from November 30, 2015 through November 30, 2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">6.17</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020<SUP>3</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">0.10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative total return at NAV for the fiscal year, through November 30, 2020<SUP>2</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">4.46</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of November 30, 2020<SUP>1</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right">2.03</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You should not draw any conclusions about the Fund&rsquo;s
investment performance from the amount of this distribution or from the terms of the Fund&rsquo;s managed distribution policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The composition of this and subsequent distribution may vary from
quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized
appreciation of portfolio securities and net realized gains on sale of securities is $166,957,956, of which $162,923,941 represents net
unrealized appreciation of portfolio securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The amounts and sources of distributions reported in this
19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for
tax reporting purposes will depend upon the Fund&rsquo;s investment experience during the remainder of its fiscal year and may be subject
to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these
distributions for federal income tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP>The Fund&rsquo;s current fiscal year began on October
1, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP>Cumulative total return at NAV is the percentage change
in the Fund&rsquo;s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September
30, 2020 through November 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>3</SUP> This distribution represents a one time payment
to satisfy annual tax distribution requirements and therefore has not been annualized for the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tekla Life Sciences Investors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CUSIP: 87911K100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">www.teklacap.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tekla Capital Management LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 Federal Street, 19<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boston, Massachusetts 02110</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">617-772-8500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fax: 617-772-8577</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">03D9UB&#9;002CSNB71B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 18pt">T</FONT><FONT STYLE="font-size: 14pt">EKLA
LIFE SCIENCES INVESTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Notification of Sources of Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Distribution Paid Date: &nbsp;&nbsp;March 31, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Distribution Amount Per Common Share: &nbsp;&nbsp;$0.43</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth the estimated
amounts of the current distribution, paid March 31, 2021, and the cumulative distributions paid this fiscal year-to-date from the following
sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other
capital source. All amounts are expressed per common share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Breakdown of the</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Breakdown</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total Cumulative</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total Cumulative</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Current</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">of Current</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Distributions for the</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Distributions for the</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Distribution</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Distribution</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fiscal Year to Date<SUP>1</SUP></B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fiscal Year to Date<SUP>1</SUP></B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: left; padding-bottom: 1pt">Net Investment Income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 10%; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 10%; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 15%; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 15%; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net Realized ST Cap Gains</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">0.0243</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">6</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">0.4143</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">49</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net Realized LT Cap Gains</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">0.4057</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">94</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">0.4357</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">51</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Return of Capital or Other Capital Source</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">TOTAL (per common share):</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.4300</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.8500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table below includes information relating to the Fund&rsquo;s
performance based on its NAV for certain periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 87%; text-align: left; padding-bottom: 1pt">Average annual total return at NAV for the period from January 31, 2016 through January 31, 2021</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">13.24</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Annualized current distribution rate expressed as a percentage of NAV as of January 31, 2021</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">7.62</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative total return at NAV for the fiscal year, through January 31, 2021<SUP>2</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: right">13.80</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of January 31, 2021<SUP>1</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right">3.77</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You should not draw any conclusions about the Fund&rsquo;s
investment performance from the amount of this distribution or from the terms of the Fund&rsquo;s managed distribution policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The composition of this and subsequent distribution may vary from
quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized
appreciation of portfolio securities and net realized gains on sale of securities is $178,869,122, of which $149,788,813 represents net
unrealized appreciation of portfolio securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The amounts and sources of distributions reported in this
19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for
tax reporting purposes will depend upon the Fund&rsquo;s investment experience during the remainder of its fiscal year and may be subject
to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these
distributions for federal income tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP>The Fund&rsquo;s current fiscal year began on October
1, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP>Cumulative total return at NAV
is the percentage change in the Fund&rsquo;s NAV and includes all distributions and assumes the reinvestment of those distributions for
the period of September 30, 2020 through January 31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tekla Life Sciences Investors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CUSIP: 87911K100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">www.teklacap.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tekla Capital Management LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 Federal Street, 19<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boston, Massachusetts 02110</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">617-772-8500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fax: 617-772-8577</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">03FMAB&#9;002CSNB9CD</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.906 CERT
<SEQUENCE>4
<FILENAME>tm213429d1_ex99-906cert.htm
<DESCRIPTION>EXHIBIT 99.906 CERT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.906CERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;4: CERTIFICATION PURSUANT
TO SECTION&nbsp;906 OF THE SARBANES-OXLEY ACT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 26pt">Pursuant to Section&nbsp;906 of the Sarbanes-Oxley
Act of 2002, each of the undersigned officers of TEKLA LIFE SCIENCES INVESTORS, do hereby certify, to such officer&#8217;s knowledge,
that the report on Form&nbsp;N-CSR of TEKLA LIFE SCIENCES INVESTORS for the period ended March&nbsp;31, 2021 fully complies with
the requirements of Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Securities Exchange Act of 1934, as applicable, and information
contained in the Form&nbsp;N-CSR fairly presents, in all material respects, the financial condition and results of operations of
TEKLA LIFE SCIENCES INVESTORS for the stated period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">6/4/21</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Daniel R. Omstead</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Laura Woodward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Daniel R. Omstead</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Laura Woodward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Treasurer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A signed original of this written statement required by Section&nbsp;906
has been provided to TEKLA LIFE SCIENCES INVESTORS and will be retained by TEKLA LIFE SCIENCES INVESTORS and furnished to the SEC
or its staff upon request. This statement accompanies this report on Form&nbsp;N-CSR pursuant to Section&nbsp;906 of the Sarbanes-Oxley
Act of 2002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>






<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>j2134292_aa001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_aa001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 90!E P$1  (1 0,1 ?_$ :(    & @,!
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M4M(*P*:(0C'8*9C*9 A-@";-9K_H+J:HT)N)D_&-GACI_2,,[4KPX ]5]?S
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M&R\@KI_A%3;KK.A(<V95_<K*7OFJH?C'44:/J.B@FBC9/*(F#:S[OG\5/SZ
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IJM]2?I*?O6N?'U?45_YO=_\ O..K5/=>AAU[W[KW7O?NO=>]^Z]U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>j2134292_aa002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_aa002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 8P!E P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ W^/?NO=>]^Z]U[W[KW1/.]?G!TKTCN>FZQ@;<_<'>F3C
M+8CH?I3!R;^[-E!@2>.JSF,Q\J8_9N*\<\3O59>IHT$#^5 Z*Q&PI.?+HCW'
MF"PV^86@US[@>$,0UR?F!A1\V(QGJM/O7^8K\@-K5-50]G=F_%SX$X^56$>T
M\L^:^7?RIH$FC+XVLJ^N>N'I-@[7:LA]309EP(9K1M+I1V:P4>53T%=QYGW*
M$E;N6SVY?X36YN!Z'0E$6OHW XKT$?QCWM)\ZNQ)-O;4^0W\T3M;$X2KIT[(
M[8QV^>N/BMT5@*>J22H?P[<ZX6LW#79"O@0PTN'BD^XE$K.\<,$1JX]GM\AT
MBVFX/,-UX4-UN\R*>^0.EO$*_P!%*L2> 7C\@!43/D\_0/0^\Z;9?5^X?YIG
M?7831+6Y?.="_(/N'+X[:\$M.)&B7>M0,SA\OEZBGE$4\%%%5I3Q22)/+#.O
MC]^&<FE.M[M^[=NG$%HV\7-SQ)AFE(7_ &V03Z@5IFI!QT:/K_8'8E5T'0]]
M]5_/#YM],T?\(EK,[LCY3=;8/O\ W+MW)82D>?-;8FV+N7KK%=C;BJHH:5O'
M)BJJKJ:^(-/322%P5U45H0.C>VMKH[:-QL]QW"!=-2EP@F92.*Z&0.Q_TI)/
M$$]==3_S!N_9Z!LPNT^E?G)UYC8H*G.[T^%&[IJ'N7;6(TPQK7[H^,78U<-V
MUN4J)9 7BQ]=%$M[Z4 95\5'V'Y]>L^9=R*Z]%ON%J.+6K4E4>K0.=1/^E(Z
ML:Z"^4G1_P F,/7Y+J3>M+E\E@I?M=V[*RU+5[;["V3D%81S8_=^Q\Y#1;BP
M<L53JB$LD!I9Y(W$,LH4GW4@CCT*-MW?;]V0M92!G7XD-5=#Z,AHP]*TH?(G
MHP?O71GU[W[KW7O?NO=>]^Z]U'JZNEH*6IKJZIIZ.BHZ>:KK*RKFCIZ6DI:>
M-IJBIJ:B9DB@IX(D+.[$*J@DD >_=:)"@LQ 4#)ZI%^4GSJKNR-M;IR/7_:T
MOQS^&NVLI4[6WA\N<=3?Q+L;O3<E.U5!D.L?AYA&0C*SF2AJ:>HW8%>F@:.2
M>E=8J9I9[A?7XO\ 5QZ &[\PM=1.UM-]+L2'2UR,O*WG';#SX$&3@,D8%3KL
M]K?S"]R4N"SG5/Q#VY4_&+I[+U-0^X\QALM+D?D!W#52RU#U.Y.XNY;C<V2R
M&6>IEEDH*&HAHZ<5$E.7J(0I]N:?,Y/48WG,THC:SV13:6+'N(-9I?Z4LOQ$
MGT! %2,CIM_EW? K>7SO[>J,1)6U^V^I-EO1YCMSL&-(Y:FAHJV2>2CVY@GJ
M]<%1NW<_VDP@>19(:.&.6JE601I!/YFTCY]4Y8Y<GYBO2A)2RCH9'] >"BOX
MFH:>0%2:TH; _FU_,;Z_V3MQ_@Q\"*S_ $1=([-B.T]S]G;%I*2+*;YR41>B
MS>+V]N;(;DV]+1X&HE0_Q3<4T\M?GZ@N5GCHPTM?55\VX]"7?^:+:WB_J]RX
M? V^/M:1 *N>!"L66@_B<FKGSTY:LKHX8K$93<4U5\G(_CK24.SJF5=][3V1
ML/([VR;T>2Q#1[4P%;UOV#!OR"NS$2O+-)#511U$5,\,[N)0CW/V5Z">WZ$=
MB;OZ50GQJB%S0CM!1]=3Q-#FE#QZL ^/O9G0_7_9_5_979G\R_O[M_:VTMT;
M:WKENJMS;+W%3X'<-9MO)T>Y-N15U5F/DOD9J5\-N7&T.043XF1A-2".2 J6
M4T(-, ="7;;O;K:[AN[O=;F>%'5C&RM1BI#+6LYX, <KQ%".@/\ YCG5$O67
M9FR/FS\>:/<7675'R1W%V!NCK_*;;RF0PE7@-U[6WSGL2-R;9KL;3X7);?V[
MVQMFDH-Y8&.T,D-/EYJ>,".D'O:G\)X]%_-%F;2[CW_; T5G=,[(5)!5E<C4
MI%"JR*!*G"@8@87J?U%_,3Q79.6VS1?+RIW)M_LK;<=-0=;_ #JZ8@&"^0W7
M#1**6DINR*3#_:4O=?7443::V@JHVKGI&J HJ9IP4\5IPX>G5K+F=+IT7>RZ
MW:82[BQ,GIK IXJ>H.:5XD];*?Q<^9VZ7S^Q>E_D]FMAY;<79E!5U_QS^2W7
M%;1GIGY387&O%%4PXM8"M/LKMBA2>+[_  #Z(Y*EG2E _:CE;(\QU*FT;[-X
MD=ANS1M+*"8)T(\*X ]/X)!YIZ\/(&SKW7H6]>]^Z]U[W[KW5'_SS^1>#[2S
MG9W5V5W5DMH_#?XU04U=\Q=[[<R*T6=[FWY6P^7:_P .NNZ^.2(S93<$TL/]
MY3!-')!%(:>:6D\;?<W4?[T>'4?\Q[I'>236;N4V*TS<NIH97/PVR'U.-=#C
M@2M,ZJ?RG^4F]OE'OV+<&:I:7:'7^U:)-M=0]/[=<4^QNIMBT4<-+B]M;9QE
M/#1T*U'VE+$:ZM$$4M=,@)"1)##$Z!3[>H>WC=[C=[GQ9 $MD&F.)?@C0<%4
M8'"E33)^5 "Q^]]%/5V/PF[YR5)_+S^3/Q?ZNSU1M;M_>.]=S]@9_-XS:V[-
MU9R3J7);;ZEZWCV[A<?LG%Y+<+93>F_\E0X$3113_88W+5]8$5J<,U".X$\.
MA]L&XN.6;O:+1BEZ\C.2%9CX96--(" M5G(2N:*S-Y=5S;DZ>W7M"OCQ6Z.M
M,?M_)R4D%:,?G-D_)+"URT]076.0T>6Q%%4M'Y(G7R*K1,R'2S6]VJ#PZ"\M
MC- VB:(*]*T*3@_L('1F>A>O>R]D8O<&[\-A/A9U_4FOP=-39OY68BFI<C4Q
MA*JMBCZYVW\FL=D<%DD\XBFK,AA\;+D*0Q0JU3!#,T<^B1\^C7;K:[MT:>-;
M"(U&;@9]>Q9P0?4LJDC&0#DY6VIODGO#/X#:FV._/Y/N<W/NG,8K;VWL!C-D
M?'FMRN8SV;K8,;B</CZ2GZ+DDJ\AD,A51PQ1QZC)(X5;W'NM1Z-T>Q'=9Y%A
MAN=D:9V"J D)))-  /"R2<#I$?S#^O.ZMA?&;869^9.=V31?(7<N\<%L'J'I
MGKJ' ;;VIL+HOKQNR\YN'?<^S]DTU'LR/<&Y=U;RH***6"EIYH<7XHV<S&J@
MBVI%>WATGYFMK^VVF.3?6C&YNX2.)**J0IXA9]*46K,P H 0M!QJ!1W[OU'_
M $>WXE?*W%]=TLO0O?\ 2Y3?'Q/WSF5K]Q8"CD?^]?4>\)(Q!B.[^F<LEZ_;
M&_=HU6B>2.G/@RE*LM/-$[2*RU(\QQZ$6R[REJ/W=N0,FS2-5@/BC;REB/%7
M7CC#"H(SUN$_"CY#;DR^2ROQD[GWEB]\]I;%VE@-]=7=N8T&/$?)[XZYVEHT
MV;W1AW:LKXI]PPF>.CW'%'-*D=>RRH\BS,RM,/,<.INV#<Y7=MIOY!)>1H'C
MD'"> TTRC)[O)\\<YKU8E[KT)^BF?-?O?+] ="9[<&S(HJ_MO?.7P?471F#D
MCCG.=[C[(JFP6RZ9:>8K#4Q8J9Y<I41NRJ])02B][ [ J?ET3;]N+[;MK2P9
MO9&$<0]97PO[,L?D#UIM_P Q#L?%[9RFU?A9UYN&7<&Q/CA7Y>I[/W<*F:HF
M[C^4VY&>?N3LS.5<[M6Y2HQ67FEPE :LR34<5-41QR&&11[>4?B/GU!G,]TD
M3IL-JVJWM2?$;_?MPW]K(3Q-#V"N0 :&AZK.]VZ"G7O?NO="GTMW3V3\?.R=
ML]L]3;FK=J;VVI6BJQV1I3K@J8']%;B,O1/>FRN#RM,6AJZ296BGB8JP^A&B
M*X/2RPO[K;+I+VR<I<(<'_""/,'@0<$=;#N-W1\?OYU^Y.LH]]=@==]$]][2
MV%/M;<'6VXNM<EE\INS*Q5]=D)=P].]@X;M3KS*YS!U$%<\W]W\U)F)</)3N
M\%*Z2U=;54RGV=2:DVV\^RQ"XEBM]Q2/2R,A)8U)U1.)$)&:Z&U%:8&68DMW
M)\.]R_'_ .0]#\5\S\!]H_([?^\\J^=V+N4=P=U4V,SW6T-='B/X]2Q]>[\V
M;2['Q\%0CR9.JW )1CF==0\(62?=:BM:=$,NQR[;N8V=]M2ZN9&JC>++0I6E
M>QUT#^(O\/V9-@':M/\ !/\ E.MMOM2GZ@V+F?G)6[*Q<6WNC=L[_P![;XZ_
MZIRU<,K+7[W&9WS/G=TXWSTV22E^\KZ@5N2BIE&,IZ&%ZJ85&I\?AZ$EX.7>
M3=%X((VY@,8TQ*[ND9-:O5ZL.-*DU:G8%%3UKC]_=_=I?)KM'</;_<&XY-Q[
MQW#)&C2)"E'B\-BJ4NN,V]M_&Q$PXO!8B%RD$*EF)+22O)-))*[@  H.HOW+
M<KS=KMKV^;5.WY #R51Y >0_,U))Z!GWOI!U[W[KW5U?P2[^W#NOJ.FVMCJR
M27Y!_ ZKW!\F_C)52RJM3O;J2G$3?(SXZUM4R25<V'SFUIZC)45-3!JIW,RJ
M5@@TBC#/R/0]Y=W*6:R$*G_=GMQ,\']./_1X#YT*U8 9X^0ZVY_]F-ZO_P!E
MR_V:;^,/_HG_ -%G^EW^)>-/O?[L_P  _O!]K]IY/^+YX_\ )OM=7D^\_9_7
MQ[:H:T\^II_>EI^Z_P![ZO\ $O!\2OGIIJX>OE3UQU5?_,+[PEP?R*J-QQ/#
M-MOX$?&?>OR+E@JXH:C#Y'Y$]SSOT[\?\-EX9&\GW.!J:]\M 5TV$YMJ<J%L
MHQ]IZ!_,VX>'NAE']EMMH\^>!FE_2A!^RNH?;UIC5E959"KJLA7U$U975U3/
M65E74R--45554RM-45$\KEGEFGF<LS$DLQ)/M[J"F8LQ9C5B:D]1O?NM=>]^
MZ]U[W[KW1\_@S\ ^_P#YK;T'^C&([-V5M7)T+;I[CS25U-@-K5<<D-5'2X22
MD,-9N'>,,)6>&AHY$:*\;U$U+'(DIJS!?MZ$?+W+>Y;]/_BGZ=NA&J4UHI^5
M,LWF /E4@&O6R=\?OE!\2>A/D5C?B_T=EZ7N[?N5BAE^4ORS[4[?P%'N#*UF
M 3#[3P]+3[XWY6QCM;+XG)Y.EA&"PU9'3XVACE^SBK*I:P1MD$BIQU*>V[OL
MNV[H-HV]A<7)_P!R+B24!B111WN?U""0-"FBBND,=5*]?YL/\OS:&[.R>V>^
M_BQNFI[!WS14,/:GR%Z?H,A/NO(X7&[BJ:_[[?\ L[)K)5O/34TU&E3EMO"6
M:JQ-)6T]7 D6/FIX8[(V*'H-<Y<M0374VY;.YEN /$FB!U$!JU=3^563)4$,
M**0!KD>W.HNZ][]U[KWOW7NA^^+'==;\=/D3T]W52&4P[!WOB<GG*:"-)9<E
MM&L=\1O;"K&X*M_'=GY&NHS?\3^]$5%.C+9[]MKW2"_7A'("?FIPX_-21^?6
MRI2[5CK.O<]_+^@S%*W5.W/YD.T_XG1?>)_!H?A1O3K;>GS8P6.^]M]E_"ZG
M'[!R,5]/@UQ:=%_1[;K^+Y?['4J"$-;-RT&'T:[JM17'TK1O= 5X4HC?+HL_
M\RO==3%LO^9;N\-(/])WS(^+?QW+,B^G$],])Y+?7V,:&6=Z>F;,8W[EF&A9
MI6#?4E%VOD/ET5<U3$0;K/\ [^OK>'\HHB]/VBOSZUQ?;G47=>]^Z]U[W[KW
M1^_Y=OP:W5\YN\J39L)R&%ZMV@*+<';V]:2*QPVW9*EDI<#B:J:">B&[]VR4
M\L&/CD#^..*HJC'+'2R(:LVD?/H2<L<OS<P[@(!5;-*-(X\E]!Y:FX+^9H0#
MU:#\Y/FOE=J;,H/AG_+KV_C]C_'W8,-3M7<W8>W,A@O+OZLQN1>#.8/;M7D,
M@]17;5K,E33KF<K4B:;=,LLP+/0R/)7U5?Q-QZ%O,&_O# -BY841[9'VLZD=
MY!R%).5)KJ8U,F?PFK4X=+G(3?(7#X[>GQLI/D=N&>AR6-Q_1FU*&IVE39_.
M5F"J*G!UGV/2U'CJBIAPAG6OJ(Z9 )H82LSJ@9DN>'IT![#4=S59[474M"!$
MHTU)&#2(#AQ-.(&>KB^H.V_F'T=6YC:_QL_E+;L^.NZM^YC:6-RG8>'V!WON
M"EC7%9VFJZ*DS^9WMMS=F)78U2\LD.5\,D.FAFFEBFAJ4BJ(J$ \3T.+&]WS
M;V:':ME>UFD907"3-P-0"75AH\FI3!)!!H173_-:Z;ZFZ:^8N^*+I+,;9R'7
MV]:4;WI\-M3(8VOQNQ=SSY[<&V=][$ECQDTD.&JL'O3;%<XQKI!)CJ:HA@\8
M1$9K*21GH+\XV-E8[Y(NWLAMI!KHI!"-5E=,<*,I[<:00*=5N^[=!;KWOW7N
MO>_=>ZV2*#L=,?UENK?VJ=,UN_\ DS[!W\<MY#JJNT>N:KLGX=#<?W(J3;+T
M&U.TCR90QFJ;B,\Q*W0U_P!M_L]2FMUIM'N<^(^Q(]?^&)KMM7VA9/VGAY=!
MY_,RJ(3TO\S*'R#[N#^;%M6LFIR")(Z6N^*^[DHYV! _;J&HY=)_.@^_+Q'V
M=)N:R/H+Y?Q#>5/[;=J?X.M?KVYU&O7O?NO=>]^Z]UL:=+=O;:^.?\F[:U-U
M/#+#VS\I^R>SMF=F[DPM=B,=FMJ8O&YG,X'.;@K,_FZBBQ6WJ/%=?P8"@IY:
MRIIZ>AJ-Q"J1EEDN[=*OG@.I0L+V+:^1D%G_ +FWDLBR," 5 )!))H% 30!4
M@ O7B>JD8ME;6ABCA2LVT4BC2-3+O[X=3RE44*IDGGW')--(0.7=F9CR23S[
MO7H%B"$"E4_WNV_Z"Z%#I_:G2S[DS%7O[O/(=#TF$Q55'C-Y[%I/CGO;<U5F
ML@F.HGQ&%@V/O/;V<H8:G YJI>3)TU488C ].6\I*KX_+I78PV'BL;FX-NJK
MAD$#M4T%!H92,$]P-!2G'HT6UN@]E]X9&3KSXP?/GY'=G=U96DDEV?L_.8IM
MO;?KI::6!JVHW!G\;W/GZ["X6@HG>:HJHZ*J,$:%S&5!]UK3)&.C>';8-P;Z
M7:-RNIK]AVJ1I!]=1$K$ #)-#3TZ!?\ FJ]?;#Z1[)ZGZ(PN[INR^UMA]=56
MX_D=VC75LE;F-Z]S]F[DR.[LW49QZB6:K2NI<9+2R4Z2N\L>,J:2.1WF21VV
MI)%?+I#SA;6^WW4.W1OXMY'%JGD)J7ED8L:^=:4I7\)4'->JK_=N@?U[W[KW
M7O?NO=7IU.%G?XPX;!)4TC5]-_)PW+NJ=0\_CBQ==_,"VINBD#M]O<5-10X^
M>-5MI,\3#5H&OW3S_/\ R=2$8S^Z%CJ-0V-F_(WBL/Y _GT;G^93UW*FX/YG
MG7JPO55^[=@?$[YK[ QEIIWAQG7N97H_M_*TZSR2:$IZ2H>IFFB \2#PD:&3
MQU7RZ.^:K4^+NUMQ9X[>Z0?)#X4A_P I/Y?9JY^W>HBZ][]U[KWOW7NCG?$G
MY/UO2U7O#8&ZMS;LQ'47:NP^P^NMP56UZ3&YK);#F[.IMH4>8[ P^VLJ:>CW
M),D>QL7#D<8U51C)XZG,(FCD6)A4BOV]'NR[NU@SVTSNME-&Z-I )3Q-(+A3
MAO@4,M1J44J#3JT*#^2CL+M/I(]R?$'Y.8WY.D^.>CVM'38CK-LG'% U17X/
M^.U=1O([;WK&#&B8[,T% JM)>>:  :ZZZ&A%.A<.0K:\L/KMDNQ=^BXCKZBI
MU:7_ *+ ?,CI'_RY^D.R)^V=_P#4^V/@'UYON)-V8C;_ &YV!\R<-MWMG:/2
MC;2_B\61Q^TZFEZ_V9'%NJN;/"2LQ=)55L^3%+2#32PQR58VQ%*U_9TQROM]
MT;V2RBVV*0:PLCW0618M-:A>Q>XURH)+47@ 6Z-+\L_F=\5/Y<^1[=ZQ^!6R
M=B2_)SL7,9)NS.T<#@L$VSNHGK91++L_:M%3TC8-I-MRPQK1[=HXSAL94*),
MBU56Q3T[U +9;AT<;SONS\KM/:<N1Q_O:5CXD@ TQU_"HI3M\D':IRU6!'6L
MIN+<6>W?G\UNK=.8R6X=R[CRE=F\]G<Q63Y#*YC+Y.IDK,ADLC75+R5%76UM
M5,TDDCL69F))]N]1/++)/(TTS%I6)))-22<DD^9/3+[]TWU[W[KW62**6>6.
M"".2:::1(H88D:26661@D<<<: N\CN0  "238>_=; )-!QZVP,+U:E1V;V5\
M<9LA21C$_#GI#^6GC<RTKBDJ^P-P_%[Y!_(;-Q15*R>K)X_>^V,?+)&R^19:
MI*-4TEX?;7E7YUZF2.SK=R[62.VQBL0?(NUO-,?S#JOYG3\NCQ_S&=HX?9W8
M_P ;?DYN*@%5U?C<GNSXO?)Q9)EI\<>@?DMCEV3+G-R5+R0BFV_LK=M5!4.Z
MN"LE8I*N!857@1Y]"#FB!(+JUW:45M 6MY_3P9QHJWR5J'\^M,#Y$=)[F^.?
M=O972>[D8YCKW=%?A5K3%X8LUAR4K-N;DI$U-:@W+M^JI:^#F_AJ%OS<>W@:
MBO4$[G82[7N$MA/\<3D5]1Q5A\F6A'R/0+^]](.O>_=>Z$?JCJ'LWO+>^)ZX
MZCV3GM_[VS;,*# ;?HS4U'AC9%J*^NJ':*BQ.(HA(&J*VKE@I*9#JED1>?>B
M0,GI59V5WN%PMK91M)<-P"C^9\@!YDT \SULM?%3^7IM#^7?@&[T^:?R6W!L
MC+[HC7!X[I#I7?N\,+3[ZJ9M"4NT,FNS9,=O3MW.SSUL:C#X>!:2"5KR3U,#
ML0V6U84=2ML_+,'+$?[PWZ[:-WP(HG8:_P"B=-&D.?A44'F2.C?[2^6/678D
MFV]O=D[EZF^'_P 1<CMVMIM@]/?Z5L;U5W[O"MH<VE N&[)Z_P 30X/.=;[&
MKU$LT6-PE=%)D59/N:NKH:UJ=M4I\ST=P[S:712*Z>&QV4J=$7B".9B#2CH
M"B'CI0]WFS*U.JW/D7_*IZ$^2'^E'L'^6MN[&5N7ZYR=+%NGIR;<^,SVS-Q#
M*4$M9!6=6[Q3-9>JV]5OD<?7T38?/2Q'[VDF"FAIEI?N;!B/BZ"NZ<G;;NOC
M7/*K@O$>Z+4"K5%:QM4Z34$:7\P?A%*Z\.Z-K;DV1N+,[1WC@<OM?=&WJ^?%
MYW;^>Q]3B\QB<C2MHGH\ACZR.&II:B-OJKJ#8@_0CVYU&4T,MO*T,ZLDRFA4
MBA!]"#TP>_=-]>]^Z]T?+^7/UK@MW_([%]D=@4SGIWXTX',_(SMFN:,O3Q;?
MZP@&:P>(T$HE;6;FWDF.H8J,$R5,<LNE'5''NK</F>A%RO:1S[H+JY'^(VBF
M>0_T8\@?,LVD4\\];"PZ3[B'\N!_E&,61\F)/D)'_,XDP %4&?)0Y27+0[/>
M,4GW[4T71<[TJX\P^F1VI1'8GVW4:J>7#J3/H+[^JW[WI_NU^I^OI\ZUT^O]
MEBE/E3J[SMOK#:O=76&_>I=[TK5FU.Q-J9K:6<BB*I4QT69HI:0UE#*RL*?)
M8^21:BFE O%41(XY4>Z TST/[VTAO[22RN!6&5"I^PBE1\QQ'H>M07YJ_%[L
MW>W7.5QV\:.7)?+CX+[7H=H=L14D9=^^?B/3554.IOD?M%/779W^Y5)/_"MP
MN?/44T"JU:\,U,T'MX$5^1ZA/?MHN[BU99Q7>MO0+)3_ $:V_P!#G7S.D=K\
M2!\5"*=4:^[]1]T,OQ]Z+WU\E>X]B=(];TM/4[MW[EVQU%+6R/#CL914E)4Y
M3-9W*S1QRR18O!86AJ*NH*(\ABA*HKN54Z)H*GI=MFWW&ZWT>WVH!FD:@KP
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M/15HJ:^.685<K-,R03.T,6@<9_R=&FY[?.;^=+"-OIQ,X5BMX6PQ#$D:U)U
MU.:\<' +$_7WRLCGE@E[J[6B:&P<R8?Y?I:77(DD!0]1>9)8#&-895'J%B2&
M WCHH^FW@&AGF_9<_P#6OHQ?1>Y/EYL+!;CI=O\ \Q#K+H[&U68Q%3D9>VM]
M=VX3)YG(K3Y6FAQM#2Y[IW.YF$4$5),U5$(*;Q,\>LZF0>]$#TZ--OEWNVC<
M1;G%;H6%?$>4$G.!6(G%#7 \OET?3 57SZ[$RM?L#K7^9;TCO;M>;:.>W'@>
ML\!NSN+$[TW,,1AZK)24FUDWEMW 8^JKIHZ9S \S1PA4:633#'*R:[1Q'0CC
M/,=TYMK3=;>2\T%A&&E#-05HNI0*^E<>9P#T*GR5J\A\'_@CN^B^7_=^1[[^
M:W>O5_8O4.PH<MG)=SU6Q-G]I4N-Q._,/M*HRE/]U!MFBQU)#49K,S0QR9'(
M04M'"X2.G(T.YL<.EFZLW+_+KKO=P;G?KB%XTJ=6A9*!PM?P@ %F([B HX#K
M5&QV.R&8R%!B,105N5RV5K:7'8S&8ZEGKLAD<A73I345!045,DM365M94RK'
M%%&K/([!5!) ]N]0XJL[!$!+DT &22>  \R>KY/A[\.=T=";UVMBZ3:6"[%_
MF&[PH:?-]>]9YHQY+8?PKV?504E0._\ Y"34RU=+3]@45+D(I]OX%@\U)4/#
M(T<E;)3P1T)K_I?\/4B['L<VW7"(J++S,XJD9REJN/UIN/>*@HG$&AH6( VC
MOB_\<]L?&/JR@V!A<A5[HW'D<AD-V]F=CYE"=S]H=D[AF-;NK?.Y:B6>LJ9:
M[+5S$11R3S&FI4BA#L$U%HFIZES:-KAVFS%M&2\I):1S\4CMEG;CDGADT%!T
M8GWKHTZ][]U[KWOW7NB<?)SX<[8[_P CMWL?:>\-P]%_(S8,4J=>=]]?Q4Z[
MEQM-(?(^VMX8R5H*/L#8=5+S-B*YQ'9I!')$LTZR[!ICRZ(]VV.'<F6ZA=K?
M=(_@F3XA_18<'3U4_.A%377]^5_P^V/+F&K_ )>; J?AWV]49-DQ/S(^/^WJ
M[>7Q#[8S'W$8H,WV?LC$M%N+I#>F:KM!:9!0PRU#U%9()(U1%<!_AR/3J-MY
MV2W+ZM[C-C>DXN85+6TA\C(@[HF)\\"M6-1T?7OSX.]C?S'?C=\<,_O+N_I7
M,]B]*[7[*HZO=/6-*O;>P>^,QE:':M'MK-4&]\?N3K&OV?\ QV+:JU60AC,U
M+#75[$PO'!%[J&"DXQT(]RY?NN:=JM9)[BW:ZMTD!:/]1)B0H4APT96NFI&0
M">% .M6/=RX'I/=NY-@[HZ;S%!O3!9-L;NS;G8-'28VOV[E**&&,TE!1UT>Y
MJE*&K#FH1FJ)!+'*CI++$T;!WCU$$_AV$SVTT#"=31E<4*D>0!U8/'C^9%.A
MHZ#[\Z]BW9C=J1_#'9/R!W/O*IQ6U-I;,W4^TJ6B3/Y3)P0T?\#'7W5NRMX5
MV0JI'6FB_B>:KXUB=FEUR6E71!]:=+MMW&V$PA%A'<RR$*JMII4G%-$:,3Y=
MS'YYSUM$9;K#JG^7#TWG_D7U;\5*#(?*KM';FS=C8WJGJ'%;DWYC:/?]9M^*
M:OVCLY\;BY=PT77=)F,;593+UFA:K)F!(C-J-!#$W4L:$XZEQ[2SY6L6W2SL
MP=XF54$<89P'*Y5:#4$!!9CQ:E*_"!K[=E?#GY@]];OR?R2^?O:.ROC/AMS.
M):C=_?\ N*AQ.Y7Q%$SB+;?6O2F"EJMW3_P>.0_:X=:3'*P9G#,[.[7J!A>H
MUN]CWO<9SNO,DT=I&_XIF :@_#'$.['DM%ZLF^'GP@S=,L#?#[K[<W4^'RE!
M44VX?Y@'R?V;3_Z7\KCJNEEAEA^*7Q^K*BD_N!095&4P[CRYBK)*&LETS220
MQ*U2WK^SH5;'R_(*?N2)X4([KRX7]0@_\H\)IH!\G;-"<D@=7M_&[XP=5_%O
M9M=M7KBARE7D]R923<G8/8&[<I/N/L/LS=]2&-=NO?.Z*V]7ELI5S2R2!%$=
M+ TLAAB3R/JH23U(FU;19[1 8;4$NYU.['4\C>;.QR3_ "%309Z,1[UT9]>]
M^Z]U[W[KW7O?NO=>]^Z]TG-X?\>IN+_CW/\ BS9'_C\/^/4_X"R?\?%_U9O^
M5G_FU?W[IJ?^Q;X/A/Q?#_MOEZ]:N>V?]'_^ES<_@_N+_?[SR^/_ (8__P!F
M:_OM?[>K^W_O#_$O^<:/M_+;[GR\>/R^?]O5[=\O\_411?3?6O3P_J?^D5X^
MO_;5_0^W\ZXZ.EV'_I[_ +HXS[K_ $Y_P7["H^V_X<7_ .&U_P""Z/X9D/U?
MP;_?_>+5X_N?N_7KM_9\_NHI7_-7H^NOWCX K]1X=/\ B;]#3@?3O^VO^?I&
M='_Z1O\ 2;U!X_\ AO/^(_WMK_/_ * /]E5_V8SQ?W:W;;_1Y]U_OUOXS;1Y
M?MOW_P"%>>_/E][/#SZ8V_ZKZN"G[LU:S_8_3^/\+?!^&OV9TU^?1G.]O]-O
MB?\ O-_P[I_=C[^&W^@G_AOCRZ-47DT?Z)/^,O?86_7?UVU>/GWH4^7\^C;<
M?KZ?J_OKP:_Z#]'_ -8_U*?ZAT4#XT?Z/O\ 9M*#^YW^RD_Q'[N#^-?[.K_L
MSW_#@WE^]J/^+5_IV_WZW\>MHT?W?_8_SOY\GO9^'S_+AT2;3]-^^AX'T6NN
D?JO'^LX^7C=M?])CC\^MC/VWU*'7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>j2134292_aa003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_aa003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 90!E P$1  (1 0,1 ?_$ :(    & @,!
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MD3#/D:54_:& (^8ZTL/YGG_=//\ \9>_$S_Y?_;R^?V]0/S;_P LS_I46_\
MS_U5[[MT$>C&]9?)?<W7N$IMJY[874G=6T,4E9_=G;/=NRO[XTNS9J^:HJJN
M3:&7H,G@-U8"BJJ^I>IGQT.0&)J:IC--2R2DL=$5Z-+3=9;:,0R1PW$ KI65
M-6FO'200P%<E0VDG)!/1Z_Y:O:\G</R;[;Z'[:K\?'M#YS]8;TZIW#3TU#0X
MC;N W;08&MS75>3P.$HDIL;B3LV7%/B\!2T\8AH_NXHHD4*FFK"@J/+H1<JW
MAOMVFVZ](\#<(6C; "A@"8R ,#332@&!4 =;'G^S/;^_X:S_ -+?DJ/]//\
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M<DS4X1!35OD:G#/'H<BM\T6S?326UO(HEEEFF,DG@)4LQ% (ZTQVKJQY-7I
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ML*E"CTTT=+M_*]8Y/R12+<.F7@T?72QM;=1Z]%-ML6\1S!I["[,8_P"$2G_
M8S_QH=7:_&^+M'9D^&QN=Z-[XZ^P],8XH\GC?C-_-2Q6:H$A,B1?Q"?9WR#W
M7%/3)!4,B/#3SRH@*F.37Q0_D?V=#[:A>0%4DM[B)!YB#< 1]NF9OY _9UL3
M]3]CP]A8!)WQ^ZJ'+4$-,,K_ 'AZJ[>ZNI)I*DS-3/B:/M[:.U<Q6C[>-3.J
M"=Z>0Z9&!*EJ$4ZDZSNA<QUHX<<=4<D8_(2*I/SXT\^@-^0>]:7(;PFZ>[$V
M7XOC'F^E>S<C\C.U=["EVWUOA,1EZ:BP6U]M8W=>4JJ*.MW-6ZLA+51TI9J"
MG,$I/D=3%X>OG7HOW.X#3_0W4?\ NI:WD,\C]J &@50QI5CW5IP%#QX:9V%[
MX^('3V[,IG^B]L?.O;-5%E:B*AK]J?,/9O6 RN'AJY5IWEKMN?&BHW/1PU-,
M%<0/4/,FK29=0U%ZA/&G4%Q[CLEC,9-O3<4.K!6Y6.H^U8-0^RM?GTHNS_YK
M?ROWGL3)]5[0["WOL;8V8UQ9:OR._P#<6_.T\W0RQ/%-C,KV9FVI:NBH)S*Y
MDCPM#AA,K&*77"%C7VD<>G;OG'>9[<V<$LD=NW$EV>0CT,AX#_2A:\#C'0.X
M'Y1;\J>M^@.INFM@OL/N?JS=&]*#;':'3#Y7$;_[.P_9[XI*S9V[\#@Z66KW
MIF:C)8RG@CD:65*NB"4C4AL[R[IYGATACW>Y-K;65C'X=_"[!9(JAY!)2JL!
MEC4 ?,=NGUN"^%?P[W5\6-P8';6V<;C-U?S'NU=JBII8:FDHMP;&^!G46YXX
MZ3+]I]CNQEQU7VAD,/5/%C\8)!)5/+]I'JIY9FK:$UR?A_P]#?8=CFV>58H@
M'YIF3T#)9QM@R/Y&0C"KYUTC!.K91Z$Z.V=\>.M,-UKLPU];3T<]?F=Q;FSD
MXKMT[ZWGGJE\CNK?.[\II63*[FW-E97J*F9N!=8T"Q1QHK9->I4V[;X-LM%M
M(*D DLQRSL<L['S9CDG\N '0R>]=+NO>_=>Z][]U[JOW??QL['Z>S6\.P?B+
M'MW)[>W_ %>4RO<7Q*WWDI</U5V/69>"5,]N/K'/14]7_H>[*S\3O'5VAEV]
MF9'1ZR&GE0U36J#AN@U<;5=6,CW.RZ3%(29;9S2-R>+1G_0I#YXT-^( YZH;
M[?\ AEF^W-U9VA^'WR/[EZN[FHTJLAG/@W\H-_[LV#VKBF1IY)HNKMWY?/28
M/L7;A"?Y'4I55E"*8"6;+LSA!<&G$8]>H[OMBDO9F79+J>&_&3:7#LD@_P":
M;$T=?0U(IDOU4EW!BOFW\?\ ,O@>Z*GY%=;Y 5,E+3R;HW!OJAQ64EB#%FP6
M>_B3X+<--9&(FH:FHA;2;,;'W<:3PZ!=\F_[;)X=^;J)J_B+@'[#6C?:"1T#
M?^G#NK_G[_:/_HP-V?\ UV]^H.D/[PO_ /?\W^]M_GZ8-Q=B=@;OI8J#=F^M
MX[HH8)A4P4>XMSYO-4L-0%9!/%3Y*NJ88Y@C$:@ UB1?WOIJ6ZN9QIFD=U'D
MS$_X3TE*:FJ*RH@I*2":JJZJ:*FI:6FB>>HJ:B=UBA@@AB5I)III&"JJ@LS$
M "_OW3(!8A5%6/5C'2G\KGY.=F8H[][)Q>&^,/2M#!'D,]V]\ALA%U[A:#&,
M=7FQ^!S#TNY,K45,"LU,6IZ:AF.D-51AU8U+#RR>A18<H[M=I]3=!;2P J9)
MCH 'R![C\L 'U'5U_P ,/B9@-K4E,GP(VY5Y'(Y2FKL7O#^91WYLXTM)1XVK
MI#C,M2_$;I[)24N0S-35>6IB7+58@Q:!)(IJ[)Q21*M"?XOV?Y^A[L6S1PJ/
MZN*2Q!#7TR\ 10_31')\^XT7B"SBG5X/0'QSZX^..V,C@MCT^4R6<W/DO[P]
MB=B[NR4NX>Q>SMVRHPJ]T[ZW15C[O+9*=Y',<2B*CHUD9*:&&,E?="2>I VW
M:[7:X3';@F1SJ=V.IY&\V=CDG^0\@!T//O71CU[W[KW7O?NO=>]^Z]U[W[KW
M11?E_P#[)M_<2E_V</\ T:?W<^Z7^[/]\-7]\OXSK7Q?Z,_X%_QD3^]&NWB_
MN]_N1O\ H][%:]O1+O?[B^G'[\\+PJ]NKXJ_\+IWZO\ 2=W1!MLXSNC(8G*G
MH7>OR]VET-' "P^<_5_2/8?3E7B L1HUH&[F[>ZO^4./V>])XE@:N%5$H&JS
M711;'G2OR_U4Z#<27[(W[NDO4VZG_$N.)XB/*GBR1W 6G"M>BE=C5WQIQF9D
MA[0VO_(\WK5AH?NLCL/??8'5^6DKC%,$_B.&Z]ZY[>>%559&D\]?(6+Q*]BD
M;2;SY:NB6Z;:DDI=IR_(WJCO&:_,(DG\SZ?*J%EW%\#9'I5PO3_\HZCK_'3I
M'-FODA\A<GCCDP_%344\OQ6Q-,,8TA75!-+I" ZY2I-O=WSZ3F7ETT\.#90W
MSGF(K_V3C'R/[>C1]88SL'(8Z6I^*N]_@-M.I%+525V%_ER=6=']A=T/1_;)
M]]2Y'<W?O<76.*CJA3Z=,\V(>4K;7"!H]^-/.M/GT;VB7++79Y-M0TR+*.)Y
M:>=6FEC'YE?RZ$#J8?!U>S<*ORVD^1$OR#6OF&SY?YD\,]/C9:P&$32=4T\,
M]5\7H(GJ]!I4P\LE<LA C9G#DZ[J8X?+I39?U?\ JU_?7U7[SKV_7<*_\+_X
MC\>&G/IU=U!X/!#]MXOMO%']OX-'@\&@>+P^/]OQ>.VG3Q;Z>Z=#\4ICAUE]
..^ZWU[W[KW7O?NO=?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>j2134292_ba004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_ba004.jpg
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MOB1G1H      (,S5PNGSO>DH<PY1L5M K,D_3=D'+H*6)B;TR2M2SBY0
M     5 PS)?SHIZ-;=B;-&H5_+OEQU;1A&D+ *X,DO$WP          !6+)M
MG<X:*?+$/HRC\!KSZ/PRSQ,4]CV,@         'FB-JH@HF2_?+N4"1%I&])
ML        ?",9$,44,S] M.P=;Q9ENA@.?HC:J&*/!SE.I4NF[1R>4&=XG)Y
MW&>AAH_      #'1KT[@H%FX156LT_BSG)CN=U/46^XE;NN$_"KDM9;[;ZJ]
M^KP%GBYNLO1&$XHTL!JE99@ ,%QZ)RG0 %4$/1SJPW KRUV8JGK58C1N2B)\
M[0*MS&B+N^<F*2SCU4:I<]6P7G>4U8CJH(V]1*-7/(SG6X=Z2-71*X5&R1=3
MRTS[B<MRMDBC1S\T][+O0',:O^6D^!<)VLTS%;#U-HQKE*V%*/F9F\:-LLWR
MS]2-,KQ453.*WHW;M9X(KJ<MF1K  I$EY: !#%.H<V4T:%53;%'9KN&/6_EZ
MR3V?'[HCU)<N]W0DB[Z/5/PC[2        *?+@!KS\  /A'%[Y[@R;NSF;MJ
M/H-TL]$@           4B3PBY=8  !0;S(^JZ'>KM78            %/DZ-
MJ9A^(  &&CU3[@             IM-F$9)F:8VQA&U!BF&;8_#!,PP#[,0SS
M+          *6)\?!"B)&&?![ELD<(23 CA%2R3X-88Q*B[0         "GR
MT35G.)MC:D?->;TPR/$U-6;(T1EF$;4U))C%(Z6(0XE)5Y/S,*Z)L>AIS7DB
M-::<D1BGP91K"\"O2\#D,O0LXY.+2+@.2#>'39SF1<ZT.5#2'8!#2C"]"<'(
M!U:1HYH+0+I.6BPR]CE$N<L<Y0)4="G/YH#ITS@?_]H " $!  $% C?,C[S"
MI/%,?8:R5&5=P4&ULM2\S)NX,02[>+!.-9QYK:91+([%I,GO,-V33K_>8?LF
MHH=FI8:;F$\V5_".S[S'>8[S'>8[S'>8[S'>8[S'>8[S'>8[S'>8[S'>8[S'
M>8[S%IL#-2N9LUPQ;_*2_A;NL7<5?]J+$:SKDG6836FR(AT^ESJY/\0L9#-=
MK^PZS">UY?QE3I<^OC0-,F00]J4YV+&U"6Q+9U9^O>>UFZ6)-.K#9T>PCM.Z
M1(E1:6F;@QOL]E_>>EGEQ3QLI3Y0\OV((<BX<JYS.RLP:)A3UFHY;*9UAL*7
MV+FZ>M3L-N\QYFSLMV;Z3F?&RX[A5'R9S$H1<54W8(5:H[V1*C.6[FMSI\B*
MY$G[#EV;L@K[,VF0R5CL*+#+B#+B#+B#+B#+B#+B#+B#+B#+B#+B#+B#+B#+
MB#+B"QV#'D;'?TV9*V>/'E_--?&R5OMLYVPCNL7*Z*K99CSLRS3'I(-Q<C8Y
M]Y!MZZWO)D>HHK*'.3:W46>_L.S$Y O[24YJ5A.D0:]4I^EH(\QJV^TL)OS4
MRGJ6ZF/8*E0MU>I*R0]\?#Q7%]:,U0?EN% G[S:5T6IL[JQLYMG>P[]JYO[:
M*ZY:0*\]ZE+BHW>8NNJYI65;]O.NG7Q44,2F6-E_>9%C$BN?(0\4XS9GBMC%
M;'Q4#K9K(48?%P2/#8Y.U\1\DU%<@+K(3BFH$9A&*V,5L8K8Q6QBMC%;&*V,
M5L8K8Q6QBMC%;&*V,5L8K8Q6QBMC%;&,V,5L*8805C-KZX,V\J8W451PH#C4
M9E%W[@T>HG6KU%M8GZNS,L_A6OC?L5*2E+3[+XF[#&A3;S=8R+6HOH=N/FJ?
ML4^RAWZ2)4>(W&D-2X]S;MU3*J:X4^>YQV&+M<.];J*8JXAM?N'5==GLZC[6
M]EV&MZS0Z?3M^O4:?O7:URY)XFB1YX21PDCA)'"2.$D<)(X21PDCA)'"2.$D
M<)(X20X;C3:YC+<CA)'L&TM:^IH?;M)+@NZA[N70ZW_\]U4BFBO>Z]%17[_.
MA:W,]C^N&-BM+Z5JM/I=\JXA[EO^KZ[?U6XUK%-+]CW6][39>F[_ %9<'W[Z
MZB)W]5E1L-6'O/915;)[]6QZZUBVT[6NZV,,6+DM[8[)B7LUA M+"]^+E_"_
M@7)CMFT\T\7X9.\ZA$:B>UO7\S69^\;)=JB:19V\")ZII?DI6OS:"-0ZLU D
M?'5^<++V)00I7]RXZFWK6)M.OU.J:Y55%!ZVKZ6VG2=FCO:/L4*FV%STKZM;
MOU;SI35BM?LV$3=[8SG:/U+JNJ;/_;BD?$76=UI&5:39["'?5>B.-K];Z*XU
M9T=+36_TF7%^U(,]SMA,W[9M.LH&[;![$2QJ&W*)3UCJ:MF]QWM/8)=D+3RE
MCE+'L_VG%]8UFOZ54/1[?UZIBY:VK8(),W7LI@'7[C=R8E=.HV'95_(3-L]H
MM!6:E85IUU#$JV"KD$HCE$.4L<I8GP46L2NJHM0B3H$&1*BP&H)<I8<2^\W2
MZM'HI?*6.4L<I8Y2QREC;G+1-K&>LCOOK9T%3</T&J4^MNBQ@M6$:)J*(M-H
M5LNN;VO:*?2]>N/_ *<1>4-'ZP:=72(:JX?&S)S_ -FV;=<M0;;0TA2$K(>"
M\_9;+^\_0Y+9'E-C*;&4V,IL9385(:46WT\WSB^Q_9&PUWJ[4H+U=XCQ^]GE
ME-C*;&4V,IL938RFQE-C*;&4V,IL938RFQE-C*;&4V,IL938RFQE-C*;&4V,
MIL938RFQE-C;K*/%M;:V>983LD\R_'LY%"GZM3-*OSALJD_=[+^\V5+3W*<2
M)RYH'8@=B!V('8@=B!V(#S<:0$=#:>Q [$#L0.Q [$#L0.Q [$#L0.Q [$#L
M0.Q [$#L0.Q [$#L0.Q [$#L0.Q [$#L0.Q [$#L0.Q VA]ANXL[!FKA*V2$
MB6XB*@1IE-,=:3#?:2]5K>QV!CL!906W#?JB1CL#HCD(RJZ:PIJ,A).5ADI5
M<A\Y5.EI&"XYCL#'8&.P,=@8[ QV!CL#'8&.P,=@8[ QV!CL#'8&.P,=@8[
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M\+H[[(M?S&RI"VP^COM$PA2HK>"^CE]/_]H " $"  $% O\ IH?_V@ ( 0,
M 04"_P"$%<O'^[".SQ^0J69&DR47T/SXY. N7Y"I7,T(X$CRE?UY C\_D"E^
M0ALD?DJEDD$XHPA/%/V_DC!N$2O+C@0X2QS0/)?4S(@1^26O@76X.\B)?AP(
M1Q^Y<_S"6? X)XD7@E,CJ+K)KR?AU)-F?G_O<_6@R;5S'$@EM*3-1$.9#D8\
MJ!*\A*T\OQ>2'DC_ ,!3ADM#1J'2%(-!(1Q^JI+:3RB"7N1<UCE(6?E9&E]A
M YI\'+;'^[2"?=\J61C%;!-/H'0IP8<<8L<);0CZ\G/)=JQ_6(^;[IDPX/\
MQJYEY^JE)02I2EES>;;[7$@ERB'%Y9DDVR,W#"ENK"&#2$M(27!/X%)2LDH0
M@'&09DE*?I_J$,I;/_"4A*@ALD?12>1=7Z6'3^BGD)1UJ<#?Z2_6/UCB/]/R
M!]!D9N]K28K1!)>"_)'O\E,H_J<2\_DID1_\P?_:  @! @(&/P+[-#__V@ (
M 0,"!C\"^B&!KE_'YK]QGX:B:D.4XTPFN7S6(-J'VZ>]<4:/R]"1U#;0]RAJ
M7BH4Q3&?Q$$R>GE'FH34PFVZ7*<27%778E$%T*1(E1C5\2*-_P!R9\*M$DP3
MT0J5NUD^9%6CEV(T5&*CRA64R*NKCH?>G&F T,#22%;<#5U$.H_0$^9),2;5
M?.MTYY]-H>JH;HKDK\%=;4 H4IA1XF'DZ;^P+7DWS3 S3IJ(U*ZT%]Q[.GLJ
ML\$*1,K'<>]-16&XCU=?Z*GX" _%<J:T+  -+,B)+"8MM[27MC#4%&J*B8%-
MT'J+!6T"-4E;F4^'HL.4?:\W^2CE@]ZNJJ-)W4JXF.U89*W+@=ZYBZ8#HVU1
M"P !;;-VQ81IN#OQZN*AH9&^:]K,+YF@US;<A7FN:YV[/!,V-.G4=0GVX5JP
MPS26/=/MQ0,;O7>HSU+>>5',WI]31^L'_]H " $! 08_ ICIWS^N!#2?\/I.
M/N]CYH>TXDIK6M!B9G:N#+P\? 1.2*?U1X\(NUG=12M4CR->ZF5LIMHJ@999
M&V#)K\L(.-?6^7A6ISH\$M6<2HE2JS,C58319*EKM&.U1%,0TO =9X;9"Q$(
M32^)-8TEH@<;(2P<E],Q<_#B 9F'_53I.A>$\?U)RKZ+J)W2KU*T>!6VZ,GD
MTPGTN+18S/C/CPB+0V%E:82JX0KF&YBTLL,$ 5)G/+KI(Y_0(S/$.I[K29A9
M"ZN26J,7(5928,!L@8-KO QF)TD2B>-02XHW$.H\N8W 4@8^#?,!C,3^B8X5
M3E5B++D/LJ5RX]=%5E93S@MVSZ,[:XGQU];C[O8^:'M.+-9:K$NJ2J+ <O39
MSU\U7B10)P0?HUX^[V/FA[3A//58#J+"ZJ?H]V][=>6'J$6W=M],^'#'-18%
M:5FUA;!G:"QDCG03DIT&/DX6Y:;!+: L66T/6 Q@A+Q9KXQ/!XC;9ZX% V5<
MG2-#$F1$,W;)/ECNT_1Q]WL?-#VG'W>Q\T/:<?=['S0]IQ]WL?-#VG'W>Q\T
M/:<?=['S0]IQ]WL?-#VG'W>Q\T/:<?=['S0]IQ]WL?-#VG'W>Q\T/:<?=['S
M0]IQ]WL?-#VG'W>Q\T/:<?=['S0]IQ]WL?-#VG'W>Q\T/:<?=['S0]IQ]WL?
M-#VG&+4VADK#LQDHQ=)51"6&5CH;V2,CWV%""54L:TRG7]W]/#*T53C'.R?P
MNM>"*S%+TL8=%AS$$0Y&I8I@^XPF.7-,@4J8*>8,%U>GTWQ;X;S]H_<_Q%\'
M^*Z?4_\ I_\ 5:Z<KY=-OAQ;QJ\KE<(=H $<IA&UD92IM:#-]1MNI>K@9P&V
M=RC]4I_QX_\ ]A_-_P#]Z[6__AW%JJSN;N7NMCWS8"UW7<Q]FRCZ(%Q52W&X
MG&K75W!N\5F6XI_PX)=*VI%#(U5*RV-\.0FV]]$\Y>QLLK.'_>T5)%Z2 0-I
M2_U6&W?B0*PM;<!LH8O(4;]ZO9;V]2R-IV.PF8JBA='+(#$L75^E$N2>^PK0
MRTCMJO;=2!&%PGP"XNN<NZ^H_P"#%=DNKH$AM9_P05E58HEL!I21:B/&U45\
MT3<;0[9.3-EEE##XA^:##91J7BDLRQ%#)+&Y6&52XUFQ<[F2/':V.IFUM? <
M@9.UD;U"^^NGM_(85>MVDLK(VRZR#,M1GPGB:MBQCKZ14RNFJ];8I"IF%P.)
MKGTZ@5"V8D,+()V^N:7%ZX',E-)!V56Z]:Y>L\X[5NM<7:=G'YI.:CI5!7NY
M%TM%=E3Q)3.6,[MLL4Q0<K#KN)P&6QO5K*P,GF+ZL&M&>#?58ZO85.'@O.;1
MG3Z0I];B;<?#@YEBS:N5X-[$Y3?F\K?ITLCK67-A%"EE-J3G7E.6,[)"-LV+
M-JSC7TR-NVED#;./TN<W8O8P=$_"29"*GB<=-)!H$D,A?0VDZZ=:O-?%92Q:
MEM\,C6C"#B,O=K6%=-D0G(8-=D=MZ90EK@:,;]@XJI2&OMH9&M<;#/H!="Y<
M=D]%);'/LN;)3X:3)3.O"4J^#FB<#C\5>I/FP=6[DE4K-&WW&W^EU9E(2:Q&
M3@I<L9 R&=AA:J72K6&M2E%;,+O9!%^B'/H6(;5IFJUC0O81U 2HNV_NC!C]
M;+J++-3'+RR:"*=EV.!@5")(<LCK+9$2H&::Z3J0Q.W<7IG^Y_E[_P!7W?\
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MW<GF;ND^)?Y>_=RO5WZ^M_<I(I@1&)(B*=!$8\9F9GPB(CAG)8+.4R5,V3K
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M7NG$VJ5?FQ03GL%8LVT5I<QB*3\G7RP/M L"@.9(;MHQX<<SOK.,O+F/#M_
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M#'(I0B/C6^_9IR00^Q9/A-.GWUNL83$1&YF,H+'&A67\ $S4;P_S1F+-W_)
M$< )TL44(,66];.?.>Z80M%DQ/G0\!F@8"1PE?+GO'SM0:QX^%-?3G1:QZO,
MJFR!0=:UJY^Y@'JN-M;I3$X3#VU#4B\+1JF\0G'&BMSZ8F-(@2".Q*$;$MVF
MO#"68XZPX@Q3UQO%AYMC%X!6I Q)_P!GRX#"A"FTGO!V04:OI+H\J/;39<7)
MHY1BZVNO1N\62M41<-6]"QP@ P8X!0-RE8#A09F>NR2K2.I2WOQ#;# SL.)\
MZ9 PA3^(7ZZB$#]IX:O5T G!;[A> <^F)C2("J5M2W3!Z!#Q6K8#79;EJ@$(
M4/.' O7(]4/)7!@ D49"'N3'(1]W)/OQ"W;*P.!7!"TM$ E*X-EP9#W<'>:
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MN?O[D+>OZ()=@?S_ %@V](_35^9/IE+\S]&]@. &C_Z!_]H # ,!  (1 Q$
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M#PLGHQ96Z#ZI!>4(*H/2P79T/0_ '*"B1"09^([&E.9<DH+AS4;MO9AC"L_
MH1H.EN5U 7'07/A'/^'%; PQL740S9X96 9D5'#2-IAY:'.0L!58%I@N+F$#
MFKRRW.STH<<*[8+L<=T0MR,I DW%QTB+C*!?\7V1"N?A^SV5BE[*ISD*M 8J
MHD5.PIZ(IQ"8-J2_*:@+)D'"#W-P0!V5R@"QMUZ@EL8>YO@$Q!A0%@&@",*
MYO";@<K8V=U']#E";^V#$31R,9OMS)L.R:N!W=WU;-Y"E<(,GV='[0@I1NM%
MI6!)20."<!^C(1!RKC\DQ@02B"';9DYJ:(11@@RDQ8 2@P=\N%X9P\W AIGF
M$N!7E9IBS %$MD:(X3A@8## MYBC)(ZY(35)FHO".WE=A5@S3)S")1  &,:3
M'Q*H-U_!9W7LTJ\@U(_.Y&0%M*A#]]BOJ-I*Y+=D<MMWDHM3BW06PK=$EB]4
M:7C8"ZC9Y:9#-R3QU&Y9=G@5&JVK/0I3&%3@@1GU;0&J(,8WWE.X"L &8T2)
M@:[)+1!>9;P),LL8>106P.%0A=F!<U\?C,FJ!0J,">QW\BDRRQAY%!; ^ J'
M9E61$L5SN/5VY<PM,$.4>B&',F]L1J EN+.+-%$%G&PS9!J 8\E'5F98W!0X
M$2,VUR=)B*?<=$Q7Y,!G+2I6!171EY8H0U2"\M)'8E/!7$ZS']2DX'AFW*;O
M2)0%L.//%\SZ!, #I,92B<RRAFID&<M(\8]TL?\ 6J?,N 4*9AH5<9#=M,&1
MC6BZRG]:IYZGH?\ HQ<#V6%]57AF426P[6QPWV5?ZGE(T#_=4S';."978Q6+
M",1(B+__ #5!F@&+*CZ2Y"FJDO6$4% "W(,CUA[V8 ['A$#,-Q!*8D@Z 0D@
MBX8G7 )QE\M^?)NH_P"'*?AL; K(3.9RP34Q8NRHW!IJ)82BB2%)#SJ( @[?
MEL@:Q!0[2ZD]OGZ_M_%9Q-&SRG/>&+[+ 8-IFVNQNH$1\/T_ZDP?CQXEP(R*
M R+,(5I8N 13@5X?I_U)CJ]GLQRS%T,KSH%R(36[#$_ "8&"S+__V@ ( 0(#
M 3\0F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,GZ8#U&9.S"=AR/
M9R/9R/9R/9R.1[.1[.1[.1[.1[.1[.1[.1[.1[.1[.1[.1[.1[.1[.1[.1[.
M1[.1[.1[.1[.1[.1[.1[.1[.1[.1[.1[.1[.1R/_ "=RN5RN5RN5RN5RN5RN
M5RN5RN5RN5RN5RN5RN5RN5RN5RN5RN5],OMERN5R_H,_*UFLUFLUFLUFLUFL
MUFLUFLUFLUFLOAKPOAK-9K->&LIE\*>/'.1E^'KG/<8G3PG=B$N)X*^63NS3
MJ7#/1E'IE#P'J95Y_!KKFL@;Y,IFLUFO7->N:]<@\7P073G0N3NRCC>:<UFN
M<H_YFNJY#US7KFO7->N:[N:>5\_/*?/-=W->N:]<4?\ ,UZYKUS7KFO7->N:
MZ?E.]G'@#9BS6+\;,CD<CD<CD<-,>,3ETR\GMD<CD<CD<CD<CD<CD<CD<CD<
MCD<CD<CD<CD<CD<CD_+O3_B*Y7*Y7*Y7*Y7*Y7*Y7*Y7*Y7*Y7*Y7*Y7*Y7*
MY7*Y7*Y7*Y7*Y7*Y7*_]Y__:  @! P,!/Q"Y<N7+ERY<N7+ERY<N7+X7+ERY
M<N7+ERY<N7+ERY<N7],]"G5ZNO+B\=?#;GIG%)UYVWC4_0N,;"R= =UT,X4[
MY]D?4=/BP%T!9?G&?3P?=(4T&P[V'Z#+1FD2"CW50-77IFSJ*G*]?;@Q)H3Z
MI2.FE7C: LZ'/VS_ "S""ON)]E_0/HVAI5X<N'KK>.*J:O-+N^MKZ_HB@JAD
M97N%[!VUSQZYI_=4E!)7H>8:,1H;5'5%?Y^'4%=!EBAJ,[\S]\O@E+A_R.O;
M7?&76FW3&;ZA#ZA]3IX0IT51/<3>NIWR5?1_^F(* "AU9+/:GCZW!68\% 3V
M<&==?>4)?F8HC:A@9Y 'B/4*UXQWD*$-;"+ZC7IA?%K'HB_,9[.$%S@+-P(!
MV#]VK\,J,$VO!,T;%3?OQ]>GA:4]I[GLNOFRCOVAI8FPV=PYU@7(T9ZDN^OK
MFLH@>QK":+$IUH,]H/S[LWX%#!:-MEY_8Q9I 1K;<^AO3SD2&J70\-<@,[Z:
MG(L%*-4$?F0>6WG%A!,&D1V>\X>]SG0J33V#TX.M<))#<@*'!N:&^Z^!><'N
MA/XQP",@72RH=%A7ES@1[#:^@8L%JL@_@SCKC6$G74?S?7#:!F70/9'>NN\:
M]4)2^P%3YQQF*=62 E4*G(%YK.L_$C#/JAA% >C?Q@""NIA)H<=RB/R@/;EC
MC*9N5H#L,AKC->,C(5):!1W<>N-B@G>T:JG4WS??.%SW;5=H=@= 0T>(CWJ-
M#41L6FW2-DRTJ*$Z?/*G"#$:=L8]@$%G>.-=]]S"U,TT_(*(^PQQ ,I[K8NC
MXUSO66J0;$RG9(-'L#L#'A0LM11 @0A-ITXQ-21./7@\^O;$(+(;%T )K:PJ
M"H6\0+MFQ^S"4[1'12.08%*0]B5%M7J@4I>3:Y %Y=@7Y>I3EJFGSC)CL WS
M<V--("E$! ,J6!K'?W< ;L6\4+$+J[P@*>5I.J&C@C:?+%M/AIXMBV[;Y;W@
M4+G?/>!>.OB@M'#Z'C=KZ@+Z3 82DFZP>8:[.^>-3- 21@&Z<B;&P0C%F_9!
M!H="2HCI  VJ**TT(FC3CMN?5K;,&2Q1.FC?IV*<&%F[,]!U+[V'KK\#XTZ@
M'MOE>AR],!!1/K:KJ S8S4K,M"Q0(<"%!8<(Q2G9I!HY;= GOT$S2<P)P>*U
M3BD79&5AK% N^CS 2::=,ZYI;MI4-:Y )P  8.'2W:Q>FA6=]=^<""+1 'K/
M-W2@32=4*BY.);" NM@20AD,P^7O.+^^!:-^:?3C A#CQ8<D@HQIKT=Y5"A"
MI[L"N'E!MI4Z6B!#4U.ZA!#! @X$.#H<>#DQ)$[CR8^FGJNEI2)VE;"NB?E7
M;>H[+8G"4&.(<M K8<#T%7Z=O!8(INND,?E<JN(:-#YHFAL3504F!NT,.0+@
M D7<&[? J=X#1";I((S$%!J;TS.25>IO&='TDV4]4UU#@YF1*-X.CDHN]ELQ
MO84\>G;?IU_;-Y[Y! 5X/3^L.'!@$ G]>$+>OQB"1X<6"/2T+M2O%YEB,<@E
M,: 25=Z,HSFEUJH<JHC2>N,!%;7J^OIQG0.$OI^B 9>1.5?L!]<<8P2_(^0K
MUPQ*R/:-OO\ 'TRF4RF4RF4R# E#W.,#  "'H=LIE,IE,IE,IE,IE,IE,IE,
4IE,IE,IE,IE,IE,IE,IE/_DG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>j2134292_ba005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_ba005.jpg
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M  (1 0,1 ?_$ 14  0 " P$! 0$            &!P0%" ,""0$! 0 # 0$
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M@2 P\)% 4*&QP='QX6!P@/_:  P# 0 "$0,1   !_>X^$
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M-&(629(BHW$2?6&B!Y._-66L"TBQ2ZH%-^9H&OX2QBZ7;#(O.D,+@NT-S?,
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M<RLN#5%GRENB&*HY?HYE9,C'B1.7X 1A1$5S'E:]5U(J8C\M\N1>&K0F7C;
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M0+5NVU4"2#B/A62>F^-%SX'%H9:/,L-[5-X$VGW"00Y &W?9P!!ZR'P[OYB
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MB><ONN@W#Z&C+^K8_%((B6.(\)V8WK2"T:??J5L+Q3"[5'(*I+H ,!,(  %
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MH9_)$:9CM?U!U?Z@%Q/#G'[#ZD?!^P^C_'Y$8YBC^_:8#CP>L+[NKU?@V_\
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M  )()(               .LVVVVVVVVVVVVVVVVV +^(     !
M %DMMLMDLVDDDDDDDDDD@']MMFDDDETDDDDDDDDDA       " 2
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M,!O\0) X   /BZ )RMXAVNZ2+4K5H!:Y1EJ%+"<RCK5AD-:E=$0:H4,&#H-
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?+R4@=!OOU[/,?7#[@</W.Q^3B>&2@U]X %''_D__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>j2134292_ba006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_ba006.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )P"Z P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=)W=
M^[-O[#VGN;?&[,G387:VSMOYC=&Y,Q62+%28O!8#'U&4RV0J9&(5(:.AI9)&
M)/T7WL DT''IJ>>*U@>YG(6&-"S$\ JBI/Y =5F;5R_;VYN_/A[W3O+=V_MI
MY[Y YWLFOC^/ISN2I=B=<?'+"]%[ZS>)P>?VG2P1X_/=FY3?61VCE\]FLB4J
MZ#(O'BZ14I:9EG=.D*RBE!Y_.O\ @X] ^"2_FW.PW&XDECENFD/@:CHC@$+D
M!E&&D+F)G=LJU$6BC-JOMGH:]>]^Z]U[W[KW7O?NO=)[=>[=K;$V[E]W;VW'
M@]H[5P%%-D<WN/<F4HL+A,304ZEYJO(Y/(S4]'24\:CEG=1[V 2:#CTU//!;
M1-/<.L<"BI9B  /4DX'2/ZA[KZJ[[VD=^=.[WPO8&SQE*W"?W@P+SRX\Y7')
M3R5U$LE1!3LTM,E7'JLI4%K7N#;S*RFC"AZ3V&XV6Z0?4V$BRV^HC4O"HXC^
M?0H^]=+>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@1[_\ D3U+\8MB0]D]
MS;DDVOM"?<6'VO'D8<7D\S,<IF3421 4&(I:VN>FHL?0U-952+&PAI*660W"
M6-E5G-%X]%VZ;M8[-;"[W!]$!<+6A.3\@"< $GT )Z%_^*XO_G94'_ #^*_\
M#*?_ (M?_.R_SG_ #_F]_F_\?=>E^M/4<*\?+U^SY]5U_,J?O[H[9&\.\^N_
MDEO6IW=E>PNH=C=:]-9C9/4^2ZE;_2%VYLO9,>!J,-!L(=I;CRD6.W'6U#U-
M'N6DKIUB  "1*H=CTL=)&*'.:\/V=!/F [IMMM)N5I=R&=I8DCB*1&+OE1--
M-'B,:,342 G\NC2=*=R93?'\2V+V=MVGZY[UV<E0-X;#%8]3CLUB:>N./H.S
MNM<A4K%-NGJ[=1,<E+5J&FQM3*^-KQ#7T\T?NC+3(RO^K'V]'6W;@]S6VO$$
M.Y1_$E<$5H)(S^*-O(\5/8U&!'0_^Z]&G7O?NO=)3?6&W'N'9VY,'M#=LNPM
MTY3$5E'@-Z0X:@W%+MC*S1%:/,K@LH\>.R_V4UG-/,RQR@:6(!][% <Y'3%S
M'++;O'!)X4S*0KT#:3Y'2<&GH>/3[C(\C#C<?#F*RDR&7BH:2/*5^/H)<505
MV1CIXUKJRBQ<^0RT^-I*FI#/%3O5U+PHP0RR$:SKIU X0"0@R4%2!0$^9 J:
M#Y5-/4]3O?NK=$1^<E15;T@^/GQFQR?=#Y)]Z[;P>_<;>2#[SHSK*DK.U^XZ
M>6M22!:6ES.$VK38:8:P\\>7,2!F<*7(\5?T'\_+H,\R%K@6NSIGZRY4./6&
M,&67/D"%"'UU4'3EB,C-V/\ S -U/!$E;MGXQ_':@V<]</%XL;VI\BMU8G>>
MX<0^J)GDRE!UIU9MRJ&B0-34N:_<7351,WN$7S)_D/\ B^KQN;OFAZ"L-G:!
M*^DD[!V'VB..,_(/GXAT=SVWT(^B+83M_P"2W?6\-_M\?8NC]E=([(WGG]A8
M?N'L_![Z[+RG9FY=FH,)O5=H]=[5W;U5346UMN=AT>0PIS,^X)5K)*"66FI9
MH=$K.%44#54L1P_U5Z#4=_O&YSR_NKZ:/;HY&02R!Y#(R8?3&K1T59 R:RYK
MI)"D9Z$3XC][9[OWKC<>=W10[>_O!L3L_?/4V7W3L:+*1]:=B9+85;3T%?OC
MK(YNIKLN=GU];/)2!9ZBI:#(455"M14QQ)42Z=0IH.!%?^+Z5[%N4NZ6CR3!
M/%BF>(LE?#D*&A>.M3H)QDFC!A4@5)A-W;KV]L/:FY]\;NRE/@]I[,V]FMU[
MGS=4LS4N'V]MW&U.7S64J5IXYIVI\?C:.69PB.Y5#8$V'NH!)H./1K//%;0/
M<SL%@C0LQ/ *HJ3^0%>B+=.]2U'RDR>'^4WR.Q>4R>$RU5'N3XY_'O=+PU&P
MNL=AI,*K8'9&[MCM'+C<QWONG&N,O-59%JJ3;D=;%0TR4]12R2%QFT#0O'S/
M^KRZ#5A8MO3KO6[JS1L=4$#?!&G%)&3@9F'<2U?#J% !!/1A-G_(W9F[?D7V
M[\9:''Y*EWET[L_K[>64KG^V;#9+%;]IZN:GIJ'Q2?<TU;AEA@\Z2(%9*N-H
MV:SA:%"$#^1Z-8-VMY]VGV=01<6\:.3Y$/7A\QBOVBG0[Y3)4^(Q]5DZN.OE
MIJ.(S31XO%93.9!T! (I<3A:/(96OEN?\W!#(Y'-N#[KT9NXC0NU:#T!)_(
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MG>/7G0VS-J?(O)9?;V1PW2^P^N1O^J[#Q]%LRHK5W5E>SLGN#?-3/A*58/X
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ML=MTN+IQ92@_CM8W)!/%SH>%YZOY?['2F8\UH^FW7;I(Z?$S31DG_2!90/\
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&WKI7U__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>j2134292_ba007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_ba007.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ H@!T P$1  (1 0,1 ?_$ :(    & @,!
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M[J;%0$FRH3;\VO\ \5]^Z]U,6@<'E2#_ +'_ (W8^]=>Z<(\6Y4G3_AS^?\
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M-]GEJ4-P6L!JX(]TD'=^75XSCJC<038]G0JVF)PR2@']R._%C:X8%N03]?\
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M>]@.6+ &Y!_UC^/?NO=)*7_<;E-14BASLL<+L>%ILV D-'.;*=,>4B1:=O\
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K_F]_3_:O?AU[JSO_ +IN_P#=N=_V6G_Y:G_S(S_W_P#_ /*[[W^+KW7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>j2134292_ba008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_ba008.jpg
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M77>=NX]P'Y.8"Y%4;S-/&2&%&_"H  .9\\B-#94]8/& !^V>LH]J2V%LS1Z
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M=N$[CVG(S.V.<\Q*E8O82N-U/7@,V=3'SF*2J#F3CQQ^4'KVZ1G<L1:1L+E
ME!P,E(\5M:ZCQT]T&^20,X^M:?E[UA2E _Z<LN#2Z8K@P%$R!3,J Y]F)P:R
MTFX]E^SI/]C5CIH H]XL<Z2_2OVBM8R9F4  #&I$93H(C$<YDIG@(: SF+P
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M>OU55OV!ZJQT\W%RNX;<N-#:%KJSG%NLAFJJWV:LD1"ZTXJ.''J?,:5(TG;
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M,21%,"(C&I$4\HB(CG,S/"[.8@\)CIT*8</^8O#X*JE_V^OQ;I,?LEQ%'$5
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MK0AR2 82;@.E X_\2I2^1&9[5]T"#(8LH"P!VJ"0]'X,W^6S0$XOJ*($$/\
M=XPVHAFU$ 6'2XYSS3HQ%!ZP5<3*FXM:A!"QB:>I>C"A=Y?F*\[V3,BE53 Z
M1II+ZN&[<&6/=5$#5KIC(*NUJ8T6^3G:I&[]IH\7"N"WD+!:F%D0V:O^2&PL
M$S=0K&!8UL7]ET!:5=+^"4@+8>9X0/ $$$,=8YJ!#MV/'(W*+$*IF=A;JTX
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MYIZ*&\/2?DH!N?H/DU]W_:_Q]%__V@ , P$  A$#$0  $   <NJ  )@  !
M!1-&_$ *(    !(V5VVS "0     FW(A6V,"!!   /FZ@ :V\  (   ,W\
M F^C(    *V0   DVNH    $WP   (VP     .W    *W[H     W    TV@
M! (  &VD  )F^UX    %&U !VV\'@    !.VP0FV6  (    .FVVVQ0 )
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MQ*0-R#0'*QD5'H;MB VD>-= (JD= [A!"$S2]U>.Y]TX;)K>8?)F);YP80L
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M@(@*Z=#V_)EZ!Q"XT(&%O)T/P1ZAJK<&#T1D?>OP2(DF/3%6,]7"/09G]*'
M$D2P$1!_QRTV;WH^>HB)=V0@_)AR&]6AVR7H!I$L!AU=W/YL/XK;5=N4B8G"
M9@I"%Y$591BZ[AR[N3>>P'XB-1-Z^R$_LY.!A![F/35':@^XG]'-V\S]P?G4
M%+<2]8/Z.2>1(/$H]]5-Z![#^E6]=YCTI.GN/)RW7Y$#XCWU5R!5Y8?P!X7D
M)$2_)6'JIZ2TJLN=77L_G8>X'FH3P_0DO@'NU%&3-%B1P=Q@/9]G8D\1.=>)
MC')U+A;RMQ-1>D@.ZP5ABIZ$3ZYI'3N$ (7Z]VFE;J"F-DE[-S:._+.N6KPD
M2=S)T:VBQ/4V'80GG5H;K)^GJ.XV3-+AW;#=S$_ -,W,:L2'=1Z&Z]B5VJ<%
MK+8>AU-]TLP2.JB,AWLN^I[ITT$B#4P(H]2,5!=& =)*LNG,>^K@,YX_)U7+
MJ1P&P7U?L/PH6%Y?[%$0(]%^44]$KN:1*_.W;@-^ZZ[!E=C\J&6C[B =5W7N
MLKW?H)D3N6[<>N[NR7LHC#GDBY#EV'4V#W< MJZUE'"O@;$]7*_1*-UV%OVG
MLOUF I>)?8W?C9X8>W$"@)5)DW<R.W[(1F51\[[E7597]8(/I+C:WF(CO-H\
HU=9ZO^_UO4B873]901FOD#Y:0VSL?VJ">FE]<+Q>K?R//M^/HG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>j2134292_ba009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_ba009.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X )D%D
M;V)E &3      0, %00#!@H-   ,@@  ,"$  #Z3  !-\__; (0  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @("
M @(" P,# P,# P,# P$! 0$! 0$" 0$" @(! @(# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\( $0@ K@#A P$1
M  (1 0,1 ?_$ 0<  0 " @,! 0$            %!@<( P0) @$* 0$  @,!
M 0               0(#!08$!Q   00! P,# P0!!0      ! (#!08! ! '
M(# 10!(3,1064& A%3-P(B0T-1$  @(! @0"!@4( PP+ 0   @,!! 41$@ A
M$Q0Q(D%1,B,5!A @87%2,(&A0F)R,R1 )1:1L<'A@J)#<X,T1&31\9)38Z.S
M5,0U=0<2   $ P4&!00#           !$0(A,1(0(#!!(D!187$R V#P@9$3
MD*&QX4)B,Q,!  $# @4#!0$! 0       1$ (3%!41 @,&%Q@9&A0/"QP='A
M8/'_V@ , P$  A$#$0   ??P $(QZQSJ:-/FM#)K%.IS ]VU==UEJ/: !Y<W
MX_/U=W=(VOT<19"L%_.\5 @398Y #B1JU.HU<:?&$^2/FFSK:>?%N:'Z;6QN
MO3C'UUP9P(R:0L355I<[AUR). R&1I6CNF0 ?AI-.@U^:P1$TP_/BV];?S^M
MS8 R ]7L?B[K([UBCSY^.,D*R=4XBVD$=0G"<(<ERT@@YQ8_GS:21H*VQ<Z9
M2;[+MIJI.GUGMJ*JP@99CV^UF/OY%?6!J+>]L8]5L(DC"2)4ZI7SO&<SZ.LK
M5[817F+6&-5M]&[N3.!#L?F9?DM-+:$#T>IU6_%>E%(,:'.=\O1%% ,M%L !
M!3BBYH/LM-<_*D #X1X^Y.'UNG4C(;U>Z6+Z+YVVYC,D;:XQL:V7XKQ-$8<Q
M729(\V1*M;!UT"7B\U&4  #7V=9XUY.# ]T,?T3(T>NHE;(,F2OEZ!4"Q&2
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M@  'X8;GP8)G75&<$S%\P1[]@HV?>6  T]G1WF-A'/9;#K'&09/%@,L@
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ME(A-^K=K6J2>JS<$G-Q:] \3GEZ=..E8N/&Q:ROQ+MD6NF4WZV&3C63/2'K
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M02&&$MGE]Y2I IE+5^(VI^=D$+!W,O13H#G09$?7\P>%N * 5( $JM@ RM/
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M?Q L4?;,9#)ME?"&ZN@2(#AA8"O\+ ,:&(,CQFCB:%C>IYT >0TI 7B\3;%
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M@     I,   9MD      )^    MO<@    !-P   -MH\0    -M@   MO
M   "-H@  )O"\0    /-X "MMT "     =ML>=MB"(      9-MMMG@;
M   ;-ML,  &       0*-0  70
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MD4/&6F=>J-:CDC01FBH1QR0(K%N$TL]0)>1MRBERIK.?HQA/'%+//$[\1)'
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MQCB9L9J=LF\@GYGK(P;'[?TE\'% U B9$N)X: V@AW-A[&S)I+RAJ/*OW=<
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61<  E(";2E]:'*:41+J'L$=O^&__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>j2134292_ba010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_ba010.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ C0$] P$1  (1 0,1 ?_$ :(    & @,!
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M $+?W#_TM?W;RO\ HZ_TH?W@_P!'7][_ +63^"?WU_NI_OY?[M_>Z?NOL?\
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MPN96MH5D]U[IZH=F=Q[>V[T8_3NQMW;&W-#5=D[2[HS-1C\UMS#Y#:N]1N'
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M\OM>OQN!R.:V/MX=_;"WUN;9=8VS,93XC(4_7/7D-;BZJK03/DHJ.35+4/4
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M0DD_J]CK?1:-C=,]=?SO_D[W9\EOD-U?MCN[^7Q\=AV%\1/AGUON/(+4]?\
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MV<:QQ#R'^$GB3\R23Z]"#HW;_P K.W?_ #AR?_UP]^QTISU[1NW_ )6=N_\
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M)#$ES8VBIJD8JH9BWP+&2&%*=S&E0:*:'BI=J=Y_(_J3&?Z-NY/CQW!W3O+
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M_27OO;>S=N8/>78?]V.J.]8MM?WYW/C,;2YO=O\ =Z++U:T/W\]1]HM5,(M
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MYY8IKD:Y-$CRZ-MMV=MOG+M)KC"@)7X@3\1/EQ&*>1(/S-Q_"LW_ ,]36?\
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M )Z\/_\ 4GOW7L]>_A6;_P">IK/_ #UX?_ZD]^Z]GKW\*S?_ #U-9_YZ\/\
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MU-9_YZ\/_P#4GOW7L]>_A6;_ .>IK/\ SUX?_P"I/?NO9Z]_"LW_ ,]36?\
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MR%2M2U3 ONO=6*3_ , _C^,^Y_@_]Z?X/G/X-Y_LOX__  #[W;W]Y?X9Y/\
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0.KW[KW3Q[]U[KWOW7NO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>j2134292_ba011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2134292_ba011.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ D@'* P$1  (1 0,1 ?_$ :(    & @,!
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M>[>Z]DHX]X[(Q.$R&$&0H:?)44LU;NS 8>>">BJI((9A-1Y*15U21A9"I+
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M&1J*YZ<N8FK)Y)BID=F/NO="#[]U[KWOW7NO>_=>Z][]U[KWOW7NB@?R]O\
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M[<G[ISO;&!W7A,"E=VA5[EI<9C=X[OQCUNT:O'_#ZDR%%GEH-O+CZZKSN/\
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M_P#GIE_ZN-T"GO?1=U?#\\_^W=/Q!_Y91_\ N+3^VD^,]23S-_RJ&W?Z:/\
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M<_\ BO&T?_?B]K>Z1?"?MZ&'N%_R5X?^>8?\??JG#VYT NK]O@U_VZ?^:?\
MVM>W?_?1[#]M/_:#[.I*Y<_Y4O</]/+_ -68^J"?;O4:]&$^(_\ V59\9?\
MQ8/IG_WXVW/>F^$_9T:;)_R6K/\ YZHO^KB];U'M+UD3UJO[=_YDK\3/_%*_
MAY_\#GUS[L.'4<<Q?\E5_P#2K_QT=<_>^B/JY[XX_P#9'6#_ .UIN+_WJ,A[
MU^+H>;9_RKX^T_\ '^F_W;ICI>=8_P#'\8'_ );S?^XL_OQX'I78_P"Y2_G_
M (#UK2_S1?\ LNGO3_J,V7_[[O:7MV/X!U%?./\ RLMU]L?_ %9CZ(![MT&>
MKZ=T?]N,^O\ _P .6O\ _@D]U^VA_:]27=?].]A_TP_ZNMU0M[=ZC3JQ+^5+
M_P!EY='_ /!.S?\ WSW8/NDGP]"WDG_E88O](_\ QP](+^8K_P!EJ]_?^'5C
M?_>4V_[VGPCI#S1_RL%U_P U/\@Z)5[MT0=;E?\ *U_[(0Z)_P""=E?^_?[
M]IG^(]3YRG_RKMK_ ,TS_P >;JP'W7H0]>]^Z]UKC_(3_F<V_O\ M;0_^ZVA
M]W'#J+-U_P"2E/\ \U6_P] U[]T7]77]6_\ 9+O7W_:IW7_[\VG]Z_$>I"C_
M .2+!_I5_P '2>]VZ1="OU!_Q]%%_P!19_\ =%N+WIN'Y]&.V?VY_P!*?\(Z
MT]OD?_S/GMO_ ,/S</\ [G2^WQP'V=0AN_\ R5[O_GIE_P"KC= I[WT7=7P_
M//\ [=T_$'_EE'_[BT_MI/C/4D\S?\JAMW^FC_ZM/U0][=ZC;J[+^1[_ ,SY
M[4_\1I!_[OZ7VW+\/Y]#_P!O?^2I-_S0/_'UZJ'[/_YF'O+_ ,.')?\ N0_N
MXX#[.@=NG_)4NO\ GIE_ZN-TA?>^D/6^?T!_S([J+_Q'&SO_ '0T/M*W$]9'
M;7_R3+?_ )H1_P#'1T+OO72_J-6_\ ZO_J&G_P"M3^_=>/#K61WK_P ?ENW_
M ,.;/?\ NUJ_=^H@E_M&_P!,?\/37AO^+OBO^UE0_P#N5%[]TTWPG[.KPY?^
M9#=(?^(_ZZ_]XU/>AQZDO<?[./[/\@Z#CW;HJZ%#K#_CY:3_ ,,?M?\ ]S^G
M_=6\NC7;.,GV#_+UI>;Z_P"/WWC_ .'5N'_W;UGM3UC_ #?VS_Z8_P"'ILV_
M_P 7_!_]K?&_^YL/O?31X'J[3^<5_P >[\4__$:4G_N#2^V8O/J2_</C9_Z5
M_P#GWJC3V[U&O5YW\G;_ (]?Y7_^(WJO_=?6^VI?+_5Z=21[?_V=_P#Z2/\
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M />NEJJJ*%4 *!@#@.I/^R(?&;_GE^P/_1__ "%_^VG[]UOKP^"'QG'TVQV
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MT_S=*S='\L7X0;X3&Q[TZ8JMWQX:F%'AX]T=J]T;@3%48"@4N-7+=B5:T-,
MH]$6A>!Q[]4CAT]-:6MQ3ZB*.2G#4H:GV5!ITD?^&A?Y<G_>,6V__0Q[/_\
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..^Z]U[W[KW7O?NO=?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
